Section 35

EurekaMag PDF full texts Chapter 34,110


Leventhal, P.S.; Feldman, E.L. 1996: Tyrosine phosphorylation of focal adhesion kinase and paxillin during insulin-like growth factor-I-stimulated lamellipodial advance. Molecular Biology of the Cell 7(Suppl ): 392A
O'toole, E.A.; Yurko, M.A.; Woodley, D.T. 1996: Tyrosine phosphorylation of focal adhesion proteins is critical for keratinocyte migration on extracellular matrix. Journal of Investigative Medicine 44(7): 401A
Henry, G.; Ives, H.E.; Wilson, E. 1996: Tyrosine phosphorylation of focal adhesion-associated proteins in response to mechanical strain in vascular smooth muscle cells. Journal of the American Society of Nephrology 7(9): 1677
Molloy, C.J.; Fleming, T.P.; Bottaro, D.P.; Cuadrado, A.; Pangelinan, M.; Aaronson, S.A. 1991: Tyrosine phosphorylation of gap by the pdgf beta receptor correlates with the activation of p21 c ras evidence for a direct role of p21 c ras in mitogenic signalling by activated tyrosine kinases. Journal of Cellular Biochemistry Suppl (15 Part F): 232
Au, K.; Soulliere, J.; Gurd, J.W. 1993: Tyrosine phosphorylation of glycoproteins during ischemia in rat hippocampus. Society for Neuroscience Abstracts 19(1-3): 1664
Seshu, J.; Mallavia, L.P. 1998: Tyrosine phosphorylation of host cell proteins by Coxiella burnetii. Abstracts of the General Meeting of the American Society for Microbiology 98: 219
Shen, K.; Novak, R.F.; Brooks, S.C.; Sebolt Leopold, J.; Leopold, W.R. 1998: Tyrosine phosphorylation of human estrogen receptor by Stat1. Proceedings of the American Association for Cancer Research Annual Meeting 39: 407
Feng, L.; Zhou, X.; Omary, M.B.shr 1998: Tyrosine phosphorylation of human keratins 8 and 19 via a p38 kinase-dependent pathway. Molecular Biology of the Cell 9(Suppl ): 164A
Barlati, S.; Paracini, F.; Bellotti, D.; De Petro, G. 1991: Tyrosine phosphorylation of human urokinase-type plasminogen activator. Febs Letters 281(1-2): 137-140
Collares Buzato, C.; Jepson, M.A.; Simmons, N.L.; Hirst, B.H. 1995: Tyrosine phosphorylation of junctional proteins controls paracellular permeability in cultured epithelia. Journal of Physiology (Cambridge) 482P: 32P
Zhang, M.Z.; Mckanna, J.A. 1998: Tyrosine phosphorylation of lipocortin dimer in activated microglia. FASEB Journal 12(4): A450
Baraban, J.M.; Fiore, R.S.; Murphy, T.H. 1991: Tyrosine phosphorylation of map kinase induced by stimulation of pi linked glutamate receptor. Society for Neuroscience Abstracts 17(1-2): 16
Ferris D.K.; Kelvin D.J.; White G.A.; Li C C.; Longo D.L. 1991: Tyrosine phosphorylation of p34 cdc2 in vitro by an associated tyrosine kinase correlation with function. Journal of Cellular Biochemistry Suppl (15 Part B): 172
Turner, C.E. 1991: Tyrosine phosphorylation of paxillin during embryonic development. Journal of Cell Biology 115(3 Part 2): 394A
Wang, Z.L.; Palvalko, F.M.; Gunst, S.J. 1996: Tyrosine phosphorylation of paxillin in CA-depleted canine tracheal smooth muscle strips during stimulation with acetylcholine. Biophysical Journal 70(2 Part 2): A47
Mehta, D.; Pavalko, F.M.; Gunst, S.J. 1996: Tyrosine phosphorylation of paxillin in skinned canine tracheal smooth muscle. Biophysical Journal 70(2 Part 2): A46
Pavalko, F.M.; Wang, Z.L.; Gunst, S.J. 1995: Tyrosine phosphorylation of paxillin is associated with contraction of tracheal smooth muscle. Molecular Biology of the Cell 6(Suppl ): 273A
Burridge, K.; Turner, C.E. 1991: Tyrosine phosphorylation of paxillin is stimulated during cell adhesion to fibronectin. Journal of Cell Biology 115(3 Part 2): 394A
Leventhal, P.S.; Feldman, E.L. 1995: Tyrosine phosphorylation of paxillin precedes neurite outgrowth on laminin. Molecular Biology of the Cell 6(Suppl ): 3A
Kuruvilla, A.; Putcha, G.; Poulos, E.; Shearer, W. 1993: Tyrosine phosphorylation of phospholipase C is essential for its activation by platelet-activating factor in a human B cell line. Journal of Immunology 150(8 Part 2): 168A
Yassin, R.R.; Little, K.M. 1994: Tyrosine phosphorylation of phospholipase C-gamma-1 is an early signaling response of colonic epithelial cells to gastrin. Molecular Biology of the Cell 5(Suppl ): 260A
Liao, F.; Shin, H.S.; Rhee, S.G. 1992: Tyrosine phosphorylation of phospholipase c gamma 1 induced by cross linking of fc gamma ri or fc gamma rii in u937 cells. FASEB Journal 6(1): A369
Liao, F.; Shin, H.S.; Rhee, S.G. 1992: Tyrosine phosphorylation of phospholipase c gamma 1 induced by cross linking of fcr gamma ri or fcgamma rii in u937 cells. Biophysical Journal 61(2 Part 2): A369
Carter, R.H.; Park, D.J.; Rhee, S.G.; Fearon, D.T. 1991: Tyrosine phosphorylation of phospholipase c induced by membrane igm in b lymphocytes. Clinical Research 39(2): 294A
Sillman, A.L.; Yellen Shaw, A.; Coggeshall, M.; Monroe, J.G. 1993: Tyrosine phosphorylation of phospholipases C-gamma-1 and gamma-2 after sIgM stimulation of B lymphocytes is developmentally regulated. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 255
Motto, D.G.; Musci, M.A.; Ross, S.E.; Koretzky, G.A. 1995: Tyrosine phosphorylation of pp36 is required for coupling the T cell antigen receptor with PLC-gamma-1. Arthritis and Rheumatism 38(9 Suppl): S233
Staddon, J.M.; Herrenknecht, K.; Smales, C.; Rubin, L.L. 1994: Tyrosine phosphorylation of protein associated with intercellular junctions. Molecular Biology of the Cell 5(Suppl ): 84A
Denning, M.F.; Dlugosz, A.A.; Cheng, C.; Threadgill, D.W.; Magnuson, T.; Yuspa, S.H. 1996: Tyrosine phosphorylation of protein kinase C delta during calcium-induced keratinocyte differentiation involves activation of epidermal growth factor receptor. Journal of Investigative Dermatology 106(4): 908
Denning, M.F.; Yuspa, S.H. 1994: Tyrosine phosphorylation of protein kinase C sigma in murine keratinocytes expressing an oncogenic ras-Ha gene prevents activation by phorbol esters. Proceedings of the American Association for Cancer Research Annual Meeting 35: 614
Yuo, A.; Yagisawa, M.; Kitagawa, S.; Saeki, K.; Miwa, A.; Togawa, A.; Hirai, H.; Yazaki, Y.; Takaku, F. 1997: Tyrosine phosphorylation of proteins in human monocytes. European Journal of Clinical Investigation 27(Suppl 1): A20
Smith Hall, J.; Bennettt, A.; Peavy, D.E. 1993: Tyrosine phosphorylation of proteins in mouse mammary tumor virus induced adenocarcinoma in strain A/ST mice. FASEB Journal 7(3-4): A145
Ghalayini, A.J.; Nordquist, R.E.; Bell, M.W.; Anderson, R.E. 1996: Tyrosine phosphorylation of rod outer segments in vivo and in vitro Effect of light, vanadate and manganese. IOVS Investigative Ophthalmology and Visual Science 37(3): S808
Bai, C.; Bailey, J.L.; May, R.C. 1993: Tyrosine phosphorylation of skeletal muscle proteins is reduced in uremic rats. Journal of the American Society of Nephrology 4(3): 763
Jarvis, L.J.; Lebien, T.W. 1995: Tyrosine phosphorylation of specific human bone marrow stromal cell proteins following contact with human B cells. Blood 86(10 Suppl 1): 594A
Rosenberger, A.; Meyers, S.A.; Galantino Homer, H.; Kopf, G.S. 1998: Tyrosine phosphorylation of stallion sperm during in vitro capacitation. Biology of Reproduction 58(Suppl 1): 76-77
Ott, V.L.; Rapraeger, A.C. 1998: Tyrosine phosphorylation of syndecan cytoplasmic domains Potential regulation of syndecan binding to CASK and protein 41. Molecular Biology of the Cell 9(Suppl ): 54A
Link, D.C.; Liu, F.; Link, N. 1995: Tyrosine phosphorylation of the G-CSF receptor is necessary for maximal proliferative responses and activation of SHC. Blood 86(10 Suppl 1): 10A
Harp, J.B.; Marrero, M.B. 1997: Tyrosine phosphorylation of the Jak-STAT and focal adhesion pathways during growth factor mediated 3T3-L1 preadipocyte replication. FASEB Journal 11(9): A1166
Tohru, T.; Hisatsune, C.; Umemori, H.; Yamamoto, T. 1998: Tyrosine phosphorylation of the NMDA receptor Mechanism and implication. Neuroscience Research Suppl (22): S44
Sawaya, M.E.; Roth, W.I.; Cohen, B.H. 1992: Tyrosine phosphorylation of the androgen receptor mediates receptor activation in human hair follicles. Journal of Investigative Dermatology 98(4): 604
Mcclelland, P.; March, K.L.; Hathaway, D.R. 1992: Tyrosine phosphorylation of the catalytic subunits of calpains i and ii. Biophysical Journal 61(2 Part 2): A326
Bunke, D.; Monning, U.; Kypta, R.M.; Courtneidge, S.A.; Masters, C.L.; Beyreuther, K.T. 1991: Tyrosine phosphorylation of the cytoplasmic domain of alzheimer protein precursors. Iqbal, K , Et Al (Ed ) Alzheimer's Disease: Basic Mechanisms, Diagnosis And Therapeutic Strategies; Selected Papers From The Second International Conference on Alzheimer's Disease And Related Disorders, Toronto, Ontario, Canada, July 15-20, 1990 Xv+675p John Wiley And Sons, Inc : New York, New York, Usa; Chichester, England, Uk Illus Maps 229-236
Gobert, S.; Dussanter Fourt, I.; Courtois, G.; Lacombe, C.; Gisselbrecht, S.; Mayeux, P. 1994: Tyrosine phosphorylation of the erythropoietin receptor Role for mitogenic signal transduction and phosphatidylinositol 3-kinase activation. Blood 84(10 Suppl 1): 427A
Gould, K.L.; Nurse, P. 1989: Tyrosine phosphorylation of the fission yeast cdc2 positive protein kinase regulates entry into mitosis. Nature (London) 342(6245): 39-45
Greenberg, S.; Chang, P.; Silverstein, S.C. 1993: Tyrosine phosphorylation of the gamma subunit of Fc, receptors and paxillin during Fc receptor-mediated phagocytosis in macrophages. Molecular Biology of the Cell 4(Suppl ): 10A
Swenson, K.I.; Piwnica Worms, H.; Paul, D.L. 1990: Tyrosine phosphorylation of the gap junction protein connexin 43 accounts for the pp60 v src induced inhibition of communication in xenopus oocyte pairs. Journal of Cell Biology 111(5 Part 2): 100A
Mui, A.L F.; Kay, R.J.; Humphries, R.K.; Krystal, G. 1991: Tyrosine phosphorylation of the interleukin 3 receptor signals its own cleavage. Journal of Cellular Biochemistry Suppl (15 Part F): 117
Rondinone, C.M.; Gogg, S.; Smith, U.P. 1997: Tyrosine phosphorylation of the p85 subunit of PI 3-kinase directs targeting Evidence for MAP-kinase association and impaired binding to IRS-1. FASEB Journal 11(9): A1354
Foltz, K.R. 1993: Tyrosine phosphorylation of the sperm receptor at fertilization. American Zoologist 33(5): 100A
Cenciarelli, C.; Hohman, R.; Gusovsky, F.; Weissman, A.M. 1992: Tyrosine phosphorylation of the t cell receptor tcr zeta subunit evidence for a modulating gtp binding protein. Journal of Cellular Biochemistry Suppl (16 Part B): 205
Volker, K.W.; Knull, H.R. 1996: Tyrosine phosphorylation of tubulin by zap-70 modulates interactions with enzymes of glycolysis. FASEB Journal 10(6): A1270
Zhou, Y.; Wang, J.; Levitan, L.B. 1996: Tyrosine phosphorylation of two cloned calcium-dependent potassium channels. Society for Neuroscience Abstracts 22(1-3): 1252
Barlati S.; Paracini F.; Bellotti D.; De Petro G. 1991: Tyrosine phosphorylation of urokinase type plasminogen activator. European Journal of Cancer 27(Suppl 3): S28
Menzel, P.; Hawley, S.H.B.; Holash, J.A.; Pasquale, E.B. 1998: Tyrosine phosphorylation patterns of EPH receptors and ephrin-B1 in the chicken embryonic retina. Society for Neuroscience Abstracts 24(1-2): 534
Vaingankar, S.; Martins Green, M. 1995: Tyrosine phosphorylation plays a key role in activation of 9E3/CEF4 by thrombin. Molecular Biology of the Cell 6(Suppl ): 15A
Beguinot, L.; Helin, K.; Velu, T.J.; Lowy, D.R. 1990: Tyrosine phosphorylation positively regulates the transforming ability of the human egf receptor. Journal of Cellular Biochemistry Suppl (14 Part B): 303
Becker, K.M.; Peters, B.; Magin, T.; Bluemcke, I.; Kaiser, H.W. 1998: Tyrosine phosphorylation prevents localization of ankyrin at sites of cell-cell contact but not binding to Na+/K+-ATPase in human keratinocytes. Molecular Biology of the Cell 9(Suppl ): 269A
Simon, H.U.; Yousefi, S.; Blaser, K. 1995: Tyrosine phosphorylation regulates activation and inhibition of apoptosis in human eosinophils and neutrophils. International Archives of Allergy and Immunology 107(1-3): 338-339
Kinch, M.S.; Burridge, K. 1994: Tyrosine phosphorylation regulates cell-cell and cell-matrix adhesions in ras-transformed human breast epithelial cells. Molecular Biology of the Cell 5(Suppl ): 449A
Humphries, M.J.; Ohm, A.M.; Schaack, J.; Adwan, T.S.; Reyland, M.E. 2008: Tyrosine phosphorylation regulates nuclear translocation of PKC delta. Oncogene 27(21): 3045-3053
Reifel Miller, A.E.; Grinnell, B.W. 1993: Tyrosine phosphorylation regulates the DNA binding activity of a HeLa cell nuclear protein. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 187
Diaz Munoz, M.; Ferrer Montiel, A.V.; Montal, M. 1993: Tyrosine phosphorylation regulates the channel activity of the nicotinic acetylcholine receptor. Biophysical Journal 64(2 Part 2): A343
Carlson, G.; Carver, J.; Erickson, M.; Facchina, S.L.; Verma, A. 1995: Tyrosine phosphorylation serves a protein antioxidant role. Society for Neuroscience Abstracts 21(1-3): 753
Tsygankov, A.Y.; Langdon, W.Y.; Feshchenko, E.A. 1998: Tyrosine phosphorylation sites of c-Cbl in T cells. FASEB Journal 12(5): A937
Morton, C.; Wilkie, N.; Boarder, M.R. 1995: Tyrosine phosphorylation, MAPK and PLD in AIi stimulated mitogenesis. Biochemical Society Transactions 23(3): 426s
Zhang, H.; Haasch, D.; Uchic, M.; Kaszubska, W.; Crosby, S.; Grihalde, N.; Suhar, T.; Janis, R.; Okasinski, G. 1996: Tyrosine phosphorylation, nuclear translocation and DNA binding of STATs upon EPO, TPO or IL3 induction. Blood 88(10 Suppl 1 Part 1-2): 55A
Takeda, H.; Ito, M.; Nagafuchi, A.; Yonemura, S.; Tsukita, S.; Tsukita, S. 1993: Tyrosine phosphorylation-dependent regulation of the assembly and functions of intercellular junctions. Cell Structure and Function 18(6): 648
Harris, M.O.; Steinmann, K.; Schlegel, R. 1990: Tyrosine phosphorylations specific to mitosis in mammalian cells. Journal of Cell Biology 111(5 Part 2): 93A
Lieberman, H.R.; Banderet, L.E.; Shukitt Hale, B. 1990: Tyrosine protects humans from the adverse effects of acute exposure to hypoxia and cold. Society for Neuroscience Abstracts 16(1): 272
Pierre, J.; Piperno, S.; Agbotounou, W.; Mousset, S.; Pierre, M.; Jacquemin Sablon, A. 1993: Tyrosine protein kinase inhibitors. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 239
Aharon, M.; Valid, I.B.; Dvilansky, A.; Nathan, I. 1995: Tyrosine protein kinase inhibitors differentially affect interferon-gamma antiproliferative activities. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 8
Lavelle, F. 1997: Tyrosine protein kinase inhibitors in oncology The end of the beginning?. Bulletin Du Cancer (paris). 84(7): 769-770
Tanguay, D.A.; Mcmanus, B.J.; Rothstein, T.L.; Chiles, T.C. 1994: Tyrosine protein kinase mediates antigen receptor-induced jun-B expression in murine B cells. Journal of Cellular Biochemistry Suppl 1994(18D): 411
Whang, K.U.; Kim, H.J.; Lee, J.H.; Park, J.H.; Lee, J.S.; Kim, Y.K. 1998: Tyrosine protein kinase receptor in human melanocytes. Journal of Dermatological Science 16(Suppl 1): S105
Bolen J.B.; Burkhardt A.L.; Bishop P.; Eiseman E.; Horak I.D.; Li Z H.; Thompson P.A. 1991: Tyrosine protein kinase signal transduction in lymphocytes. Journal of Cellular Biochemistry Suppl (15 Part B): 90
Peri, K.G.; Veillette, A. 1994: Tyrosine protein kinases in T lymphocytes. Chemical Immunology 59: 19-39
Halaban, R. 1991: Tyrosine protein kinases in normal and malignant melanocytes. European Journal of Cancer 27(Suppl 3): S4
Pinto, J.M.B.; Kirby, D.A.; Hottinger, S.; Lown, B. 1990: Tyrosine raises repetitive extrasystole threshold ret in the conscious pig with myocardial infarct. FASEB Journal 4(3): A680
Lieberman, H.R.; Shukitt Hale, B.; Luo, S.; Devine, J.A.; Glenn, J.F. 1992: Tyrosine reduces the adverse effect of hypobaric hypoxia on spatial working memory of the rat. Society for Neuroscience Abstracts 18(1-2): 715
Kobayashi, T.; Winder, A.; Urabe, K.; Brewington, T.; Imokawa, G.; Hearing, V.J. 1993: Tyrosine related protein-1 has a specific catalytic function using 5,6-dihydroxy-indole-2-carboxylic acid as a substrate. Pigment Cell Research 6(4 Part 2): 279-280
Bross, R.; Ball, R.O.; Clarke, J.T.R.; Pencharz, P.B. 1997: Tyrosine requirement in children with PKU determined by indicator amino acid oxidation. FASEB Journal 11(3): A437
Roberts, S.A.; Thorpe, J.M.; Ball, R.O.; Pencharz, P.B. 1998: Tyrosine requirement of adult males at a fixed phenylalanine intake using indicator amino acid oxidation. FASEB Journal 12(5): A860
Shurtleff, D.; Thomas, J.R.; Schrot, J.; Kowalski, K.; Harford, R.; Thornton, M.O.; Shea, P.A.; Malik, M. 1992: Tyrosine reverses a cold-stress-induced memory deficit in humans. Society for Neuroscience Abstracts 18(1-2): 1210
Thomas, J.R.; Shurtleff, D.; Schrot, J.; Moran, R. 1994: Tyrosine reverses cold-stress induced impairment of DRL performance in rats. Society for Neuroscience Abstracts 20(1-2): 1564
Sabba, R.P.; Dean, B.B. 1993: Tyrosine sources in potato differing in blackspot susceptibility. American Potato Journal 70(11): 837
Miyagawa, Y.; Nomoto, Y.; Shiraishi, T.; Kawasaki, M.; Ogino, H.; Hayashi, S.; Yagawa, K. 1992: Tyrosine specific protein kinase participates in the pathogenesis of acute immune complex alveolitis in the rat. American Review of Respiratory Disease 145(4 Part 2): A466
Mermelstein, F.H.; Laskin, D.L.; Sirak, A.A.; Laskin, J.D. 1990: Tyrosine specific protein phosphorylation in polymorphonuclear leukocyte pmn activation. Journal of Cellular Biochemistry Suppl (14 Part B): 279
Berkow, R.L.; Dodson, R.W. 1989: Tyrosine specific protein phosphorylation occurs in activated neutrophils. Pediatric Research 25(4 Part 2): 148A
Moaddel, M.; Farrell, D.H. 1997: Tyrosine sulfation and gammaA/gamma fibrinogen/factor XIII interaction. Blood 90(10 Suppl 1 Pt 1): 465A
Mizui, Y.; Kato, H.; Suzuki, S.; Suzuki, N.; Nagaoka, N.; Suzuki, K.; Hashimoto, A.; Yoshitake, S. 1998: Tyrosine sulfation enhanced the anti-factor Xa activity of a novel antithrombin III chimeric protein. Circulation 98(17): I727
Kjalke, M.; Ezban, M. 1994: Tyrosine sulfation in the C-terminus of the heavy chain of B domain-deleted factor VIII is not required for full activity. British Journal of Haematology 87(Suppl 1): 52
Liu, J.; Louie, S.; Hsu, W.; Yu, K.M.; Nicholas, H.B.; Rosenquist, G.L. 2008: Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease. American Journal of Respiratory Cell and Molecular Biology 38(6): 738-743
Dong, J.F.; Lopez, J.A. 1993: Tyrosine sulfation of GP Ib-alpha does not affect cell surface expression of the GP Ib-IX complex. Blood 82(10 Suppl 1): 73A
Pankovich, J.M.; Jimbow, K. 1990: Tyrosine transport in a human melanotic melanoma cell line. Journal of Investigative Dermatology 94(4): 563
Wiesel, F.A.; Andersson, J.; Wieselgren, I.M.; Blomqvist, G.; Bjerkenstedt, L.; Hagenfeldt, L. 1996: Tyrosine transport in schizophrenia. Schizophrenia Research 18(2-3): 157-158
Kraus, L.M.; Kraus, A.P.Jr 1990: Tyrosine tyr and n carbamoyltyrosine n c tyr in renal failure. FASEB Journal 4(7): A1954
Rahbe, Y.; Delobel, B. 1992: Tyrosine utilization in holometabolous insects Case of a Coleoptera Curculionidae, the rice weevil Sitophilus oryzae L. Memoires de la Societe Royale Belge d'Entomologie 35: 737-742
Skorey, K.I.; Huyer, G. 1991: Tyrosine vanadate affinity chromatography purification of aryl sulfatase. FASEB Journal 5(5): A1197
Sreerama, N.; Powers, M.E.; Manning, M.C.; Goldenberg, D.M.; Woody, R.W. 1998: Tyrosine, phenylalanine and disulfide contributions to the circular dichroism of proteins CD spectra of wild-type and mutant BPTI. Biophysical Journal 74(2 Part 2): A63
Cochran, B.J.; Brown, P.J.; Haddox, M.K. 1994: Tyrosine, threonine and serine phosphorylation of ornithine decarboxylase from transformed RAW264 cell. Proceedings of the American Association for Cancer Research Annual Meeting 35: 543
Valius, M.; Bazenet, C.; Kazlauskas, A. 1993: Tyrosine-1021 and 1009 are phosphorylation sites in the carboxy-terminus of the PDGF receptor beta subunit, and are required for binding of phospholipase C-gamma and a 64 kd protein, respectively. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 243
Malech, H.L.; Huang, C.K.; Renfer, L.; Rotrosen, D. 1993: Tyrosine-324 of p47-phox plays a functional role in cell-free activation of phagocyte NADPH oxidase. Clinical Research 41(2): 323A
Woodcock, J.M.; Bagley, C.J.; Zacharakis, B.; Lopez, A.F. 1996: Tyrosine-421 in the GM-CSF, IL-3 and IL-5 receptor common beta chain is necessary and sufficient for binding and signalling by all three ligands. FASEB Journal 10(6): A1311
Liu, S.Q.; Srivastava, S.K. 1995: Tyrosine-48 is located at sorbinil binding site on aldose reductase. FASEB Journal 9(6): A1477
Kitayama, S.; Mitsuhata, C.; Uhl, G.R.; Dohi, T. 1996: Tyrosine-533 is critical for the function of the rat dopamine transporter. Society for Neuroscience Abstracts 22(1-3): 369
Molden, J.; You, Y.; Longmore, G.; Lai, S.Y.; Goldsmith, M.A. 1996: Tyrosine-containing modules of the erythropoietin receptor exhibit functional redundancy with respect to growth signaling and STAT activation. Molecular Biology of the Cell 7(Suppl ): 354A
Chuang, P.I.; Harlan, J.M. 1996: Tyrosine-containing structural motifs are not necessary in the efficient internalization of human E-selectin in Chinese hamster ovary cells. FASEB Journal 10(3): A623
Ward, A.C.; Hermans, M.H.A.; Smith, L.; Van Aesch, Y.M.; Schelen, A.M.; Antonissen, C.; Touw, I.P. 1998: Tyrosine-dependent and independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor receptor are differentially utilized depending on G-CSF concentration. Blood 92(10 Suppl 1 Part 1-2): 64A
Hoppe, H.C.; Joiner, K.A. 1998: Tyrosine-dependent protein sorting in the protozoan parasite Toxoplasma gondii. Molecular Biology of the Cell 9(Suppl ): 386A
D'ascanio, P.; Arrighi, P.; Pompeiano, O. 1997: Tyrosine-hydroxylase -immunoreactivity of Fos positive locus coeruleus neurons after unilateral labyrinthectomy. Society for Neuroscience Abstracts 23(1-2): 1291
Abu-Ali, S.; Fotovati, A.; Shirasuna, K. 2008: Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers. Molecular Cancer 7: 47
Solomon, D.H.; Critz, S.D.; Wible, B.A.; Brown, A.M.; Schwartz, J.H. 1993: Tyrosine-kinase phosphorylation in response to insulin modulates neuronal voltage-gated K+ channels. Society for Neuroscience Abstracts 19(1-3): 711
Chang, C.F.; Bray, T.; Varughese, K.I.; Whiteley, J.M.; Kiefer, P.M.; Xuong, N.H.; Grimshaw, C.E. 1996: Tyrosine-mediated proton transfer in adenine di-nucleotide requiring reduction, dehydrogenase and epimerase enzymatic activities. FASEB Journal 10(6): A971
Ishida, T.; Ishida, M.; Berk, B.C. 1997: Tyrosine-phosphorylation of p130Cas and paxillin by angiotensin II in vascular smooth muscle cells requires c-Src and RhoA. Circulation 96(8): I45-I46, 10-21/97
Rank, J.M.; Weimer, M.K.; Bloomer, J.R.; Freese, D.K. 1989: Tyrosinemia 1 related elevations of zinc protoporphyrin. Hepatology 10(4): 708
Hasanoglu, A.; Tumer, L.; Vidinlisan, S.; Biberoglu, G. 1997: Tyrosinemia type 1 in monozygotic twins. Journal of Inherited Metabolic Disease 20(Suppl 1): 15
Croffie, J.M.; Gupta, S.K.; Chong, S.K.F.; Fitzgerald, J.F. 1997: Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in absence of other signs of liver failure. Gastroenterology 112(4 Suppl): A869
Van Steirteghem, S.; Goyens, P.; Lerminiaux, C.; Fonteyne, C.P.; Van Denb Berg, I.E.M.; Vamos, E.; De Laet, M.H.; Abramowicz, M.J. 1997: Tyrosinemia type I and Hirschsprung disease in a newborn. Journal of Inherited Metabolic Disease 20(Suppl 1): 15
Dionisi Vici, C.; Boglino, C.; Marcellini, M.; De Sio, L.; Inserra, A.; Cotugno, G.; Sabetta, G.; Donfrancesco, A. 1997: Tyrosinemia type I with early metastatic hepatocellular carcinoma Combined treatment with NTBC, chemotherapy and surgical mass removal. Journal of Inherited Metabolic Disease 20(Suppl 1): 3
Rabut, G.; Konner, J.A.; Dragic, T. 1998: Tyrosines 14 and 16 in CCR-5 are necessary for infection by macrophage-trophic HIV-1. Journal of Investigative Medicine 46(1): 142A
Holtzer, M.E.; Adams, K.; Lovett, E.G.; Holtzer, A. 1996: Tyrosines in two-stranded coiled coils are CD active near 280 nm even in the absence of interhelix tyrosine-tyrosine interactions. Biopolymers 38(5): 669-671
Pitzele, B.S.; Chandrakumar, N.S.; Contreras, P.C.; Allen, S.E.; Clare, M.; Savage, M.A.; Hammond, D.L.; Nevins, M.E.; Nash, S.A. 1992: Tyrosyl amides as ligands at the phencyclidine receptor located on the NMDA-sensitive glutamate site. Society for Neuroscience Abstracts 18(1-2): 1510
Willis, K.J.; Szabo, A.G. 1989: Tyrosyl and tryptophyl emission from subtilisins. Biophysical Journal 55(2 Part 2): 516A
Hansen, D.W.Jr; Chandrakumar, N.S.; Husa, R.K.; Peterson, K.B.; Tsymbalov, S.; Stapelfeld, A.; Williamson, L.N.; Reichman, M.; Beardsley, P.M. 1992: Tyrosyl diamides as potent mu and delta opioid receptor ligands. Society for Neuroscience Abstracts 18(1-2): 687
Carlesso, N.; Frank, D.A.; Griffin, J.D. 1995: Tyrosyl phosphorylation and DNA binding activity of stat proteins in hematopoietic cells transformed by p210 BCR/ABL. Blood 86(10 Suppl 1): 264A
Nel, A.E.; Ledbetter, J.A.; Pollack, S. 1990: Tyrosyl phosphorylation of lymphoid map 2 kinase reveals the dual function of cd4 in cd3 induced t cell activation. FASEB Journal 4(7): A2018
Savenkova, M.I.; Francis, G.A.; Heinecke, J.W. 1993: Tyrosyl radical generated by myeloperoxidase initiates low density lipoprotein lipid peroxidation. Circulation 88(4 Part 2): I179
Ramsell, K.D.; Watts, S.W.; Matesic, D.F.; Cobbett, P. 1996: Tyrosyl-phosphorylation is associated with morphological plasticity of RG-2 astroglial cells. Society for Neuroscience Abstracts 22(1-3): 376
Francis, G.A.; Oram, J.F.; Heinecke, J.W.; Bierman, E.L. 1994: Tyrosylated high density lipoprotein enhances cellular cholesterol excretion by a mechanism independent of passive sterol desorption. Circulation 90(4 Part 2): I241
Sane, D.C.; Baker, M.S. 1992: Tyrosylprotein sulfotransferase activity in human platelets. Circulation 86(4 Suppl 1): I151
Sundaram, P.; Slomiany, B.L.; Slomiany, A.; Kasinathan, C. 1991: Tyrosylprotein sulfotransferase in rat gastric mucosa. Journal of Cell Biology 115(3 Part 2): 59A
Bright, J.J.; Sriram, S. 1998: Tyrphostin A1 and B42 prevent EAE by inhibiting IL-12 induced activation of Jak-Stat pathway in T cells. FASEB Journal 12(4): A265
Pai, R.; Ohta, M.; Itani, R.M.; Sarfeh, I.J.; Tarnawski, A. 1997: Tyrphostin A46 inhibits healing of experimental gastric ulcer Evidence for the crucial role of EGF and MAP kinases in the healing process. Gastroenterology 112(4 Suppl): A250
Wang, L.; Kirken, R.A.; Erwin, R.A.; Taub, D.; Murphy, W.J.; Farrar, W.L. 1998: Tyrphostin AG-490 inhibits the JAK3/STAT5a/b signaling pathway and antigen-specific activation of human T cells. FASEB Journal 12(8): A1412
Liang, B.C.; Ullyatt, E. 1998: Tyrphostin AG17 chemosensitizes glioblastoma cells to BCNU by a mitochondrially mediated mechanism. Neurology 50(4 Suppl 4): A273-A274
Kaur, G.; Sausville, E.A. 1994: Tyrphostin AG957 inhibits p210-bcr-abl in K562 chronic myelogenous leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 35: 446
Kaur, G.; Sausville, E.A. 1995: Tyrphostin AG957 inhibits shc tyrosine phosphorylation in K562 chronic myelogenous leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 36: 437
Fishbein, I.; Banai, S.; Moscovitz, D.; Gertz, S.D.; Gazit, A.; Wolf, Y.; Levitzki, A.; Golomb, G. 1996: Tyrphostin delivery systems for the treatment of restenosis. Pharmaceutical Research (New York) 13(9 Suppl): S253
Warburton, D.; Shun, L.; Bringas, P.; Buckley, S.; Seth, R.; Slavkin, H.C. 1990: Tyrphostin egf receptor kinase inhibitor inhibits early mouse embryo lung branching morphogenesis. Journal of Cell Biology 111(5 Part 2): 241A
Kaur, G.; Gazit, A.; Levitzki, A.; Stowe, E.; Cooney, D.A.; Sausville, E.A. 1994: Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia. Anti-Cancer Drugs 5(2): 213-222
Meydan, N.; Loubser, M.; Cohen, A.; Dadi, H.; Freedman, M.; Grunberger, T.; Roifman, C.M. 1994: Tyrphostin inhibits PRE-B acute lymphoblastic leukemia cell growth. FASEB Journal 8(4-5): A773
Matsumoto, K.; Zhou, D.F.H.; Schleimer, R.P.; Bochner, B.S. 1995: Tyrphostin reduces alpha-4 integrin function in human eosinophils and Jurkat cells. FASEB Journal 9(3): A226
Hauge, D.E.; Aaronson, P.I.; Ward, J.P.T. 1998: Tyrphostin-23 inhibits hypoxic contraction in rat pulmonary arteries. Journal of Vascular Research 35(Suppl 1): 19
Levitzki, A.; Gazit, A.; Vardy, D.; Klaus, S.; Ben Bassat, H. 1992: Tyrphostins as blockers of the proliferation of psoriatic keratinocytes. Abstracts of Papers American Chemical Society 204(1-2): MEDI 6
Levitzki, A.; Gilon, C. 1991: Tyrphostins as molecular tools and potential antiproliferative drugs. Trends in Pharmacological Sciences 12(5): 171-174
Lamb, D.J.; Shubhada, S. 1993: Tyrphostins inhibit Sertoli cell-secreted growth factor stimulation of A431 cell growth. Recent Progress in Hormone Research 48: 511-516
Bilder, G.E.; Krawiec, J.A.; Zilberstein, A.; Levitzki, A.; Perrone, M.H.; Schreiber, A.B. 1990: Tyrphostins inhibit pdgf induced dna synthesis tyrosine specific protein kinase activity and c fos messenger rna expression in vascular smooth muscle cells vsmc. Circulation 82(4 Suppl 3): III571
Romer, L.H.; Burridge, K. 1993: Tyrphostins inhibit pp125-FAK kinase activity in vitro during integrin-mediated adhesion of human vascular endothelial cells. Clinical Research 41(2): 262A
Buhl, A.; Gadwood, R.; Waldon, D.; Kamdar, B.; Groppi, V. 1990: Tyrphostins inhibit the growth of keratinocytes and the effects of minoxidil on mouse vibrissae in culture. Journal of Investigative Dermatology 94(4): 511
Kaebisch, A.; Seay, U.; Lohmeyer, J.; Pralle, H.; Levitzki, A. 1995: Tyrphostins inhibit tyrosine-autophosphorylation of p210-BCR-ABL in vivo and reduce Philadelphia-positive clonogenic cells from CML patients. Onkologie 18(Suppl 2): 149
Baran, D.; Vendeville, B.; Luu, T. 1993: Tyrphostins reversibly inhibit PDGF and bFGF driven murine mesangial cell proliferation. Journal of the American Society of Nephrology 4(3): 594
Palumbo, G.A.; Gazit, A.; Yarom, N.; Levitzki, A.; Ben Yehuda, D. 1994: Tyrphostins, a class of tyrosine kinase inhibitors, induce in vitro apoptosis and cell growth arrest in NHL. Blood 84(10 Suppl 1): 296A
Golomb, G.; Fishbein, I. 1997: Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis. Advanced Drug Delivery Reviews 24(1): 53-62
Sklan, E.; Segal, A.; Priel, E. 1997: Tyrphostins, protein tyrosine kinase blockers, as topoisomerase I inhibitors and anti-cancer drugs. International Journal of Oncology 11(Suppl ): 927
Varga, J. 1996: Tyrrell report on transmissible spongiform encephalopathies A summary of present knowledge and research. Magyar Allatorvosok Lapja 51(1): 48-52
Kindler, P.; Davaud, E.; Strasser, A. 1997: Tyrrhenian coastal deposits from Sardinia A petrographic record of high sea levels and shifting climate belts during the last interglacial. Palaeogeography Palaeoclimatology Palaeoecology 133(1-2): 1-25
Zei, M. 1993: Tyrrhenian sea deposits of the Pontina area A submarine deposit of Strombus on the seabed east of the Circeo Cape. Giornale di Geologia 54(2): 127-141
Giusti, F.; Manganelli, G. 1992: Tyrrheniellina, new name for Thyrrheniella Giusti and Manganelli, 1989. Bollettino Malacologico 28(5-12): 231
Tyryshkin, L.G.; Kolesova, M.A. 2008: Tyryshkin L G, Kolesova M A Assembling the set samples for the differentiation of leaf rust casual agent populations Puccinia recondita f sp Tauschii. Mikologiya i Fitopatologiya 42(1): 78-81
Dunn, T.C. 1994: Tyta luctuosa , the four spotted , new to Co Durham. Entomologist's Record and Journal of Variation 106(11-12): 254
Marti, C.D. 1992: Tyto alba Barn owl. Birds of North America 1992(8): 1-15
Domashevskii, S.V. 1993: Tyto alba in the Crimea. Vestnik Zoologii 1993(4): 55
Lainson, R.; Paperna, I. 1994: Tyzzeria boae n sp, , a new coccidium from the kidney of the snake Boa constrictor constrictor. Memorias do Instituto Oswaldo Cruz Rio de Janeiro 89(4): 523-530
Simpson,V.R.; Hargreaves,J.; Birtles,R.J.; Marsden,H.; Williams,D.L. 2008: Tyzzers disease in a Eurasian otter in Scotland. Veterinary Record 3(18): 539-543
Shirakawa, T.; Maruyama, K.; Nakamura, N.; Awakura, T.; Ohishi, H.; Senba, H.; Higuchi, T.; Sonoda, K.; Ono, T.; Matsui, T. 1989: Tyzzer's disease in a foal. Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 51(2): 444-446
Ochoterena Booth, H.; Flores Olvera, H. 1992: Tzontzapotl Licania platypus , a resource of economic potential utilized since prehispanic Mexico. Boletin de la Sociedad Botanica de Mexico 1992(52): 115-120
Rice, P.J.; Huang, N.; Abraham, S.T.; Bauman, R.J. 1992: U 0521 decreases contractile responses in rat vas deferens. FASEB Journal 6(4): A1023
Rettenmaier, L.J.; Sharp, G.C.; Takeda, Y.; Luger, A.C.; Hoffman, R.W. 1989: U 1 68kd positive mixed connective tissue disease mctd appears genetically distinct within hla from systemic lupus erythematosus sle. Arthritis and Rheumatism 32(4 Suppl): S39
Cipkus Dubray, L.; Swirtz, M.; Khan, S.; Humphrey, S.; Skaletzky, L.; Meisheri, K. 1992: U 37883a a structurally novel antagonist of the vascular potassium a t p openers. FASEB Journal 6(5): A1777
Gibson, J.K.; Holzgrefe, H.H.; Buchanan, L.V. 1989: U 4006f enhances function recovery and prevents diastolic wall thickening following reperfusion of stunned canine myocardium. Journal of Molecular and Cellular Cardiology 21(Suppl 2): S162
Rogers, H.; Hayes, A.G. 1989: U 50488 h decreases kainic acid induced neurotoxicity in the hippocampal ca3 ca4 region of the rat. British Journal of Pharmacology 96(Suppl): 320P
Qu Z.X.; Xu J.; Perot P.L.; Hogan E.J. 1991: U 50488h reduces vascular permeability and edema in rat spinal cord injury. Society for Neuroscience Abstracts 17(1-2): 163
Althaus, J.S.; Von Voigtlander, P.F. 1989: U 54494a selectively protects against kainate toxicity in rat cerebellar granular cells. Society for Neuroscience Abstracts 15(1): 771
Szmuszkovicz J.; Lahti R.A.; Vonvoigtlander P.F.; Tang A.H.; Althaus J.S.; Lum J.T.; Hoffmann W.E.; Evans D.L.; Franklin S.R.; Et Al 1989: U 67413b a dihydrophenalene 5 ht1a agonist with weak dopamine agonist properties. Society for Neuroscience Abstracts 15(2): 1234
Lahti, R.A.; Piercey, M.F.; Evans, D.L.; Carrigan, K.J.; Neff, G.L.; Barsuhn, C.; Vogelsang, G. 1989: U 68553b a novel dopamine autoreceptor agonist with chronic activity. Society for Neuroscience Abstracts 15(1): 270
Shalinsky, D.R.; Sampson, K.E.; Abraham, I.A.; Howell, S.B. 1992: U 73975 inhibits azidopine labelling of p glycoprotein and selectively enhances vinblastine accumulation in multidrug resistant kb grc1 tumor cells. FASEB Journal 6(4): A1280
Holzgrefe, H.H.; Gibson, J.K. 1989: U 74006f a potent inhibitor of lipid peroxidation enhances recovery of function in stunned canine myocardium. Circulation 80(4 Suppl 2): II241
Malaker, K.; Das, R.M.; Sutherland, G.; Peeling, J. 1991: U 74006f a promising new radioprotective agent. Clinical and Investigative Medicine 14(4 Suppl): A109
Carrea, F.P.; Lesnefsky, E.J.; Horwitz, L.D. 1991: U 74006f decreases necrosis and enhances functional recovery after ischemia reperfusion in isolated rabbit hearts. Journal of the American College of Cardiology 17(2 Suppl A): 228A
Xue D.; Bruederlin B.; Heinicke E.; Li H.; Silvka A.; Buchan A.M. 1990: U 74006f reduced neocortical infarction but does not attenuate selective hippocampal ca1 necrosis. Stroke 21(1): 178
Schreur, P.J.K.D.; Nichols, N.F.; Pregenzer, J.F.; Oostveen, J.A. 1990: U 78875 a benzodiazepine antagonist with anxiolytic properties in rats and mice. Society for Neuroscience Abstracts 16(2): 1322
Piercey, M.F.; Moon, M.W.; Lahti, R.A.; Hoffmann, W.E.; Lum, J.T. 1991: U 86170f a potent dopaminergic agonist that does not induce tolerance with chronic administration. Society for Neuroscience Abstracts 17(1-2): 1348
Pilatte, Y.; Greffard, A.; Terzidis Trabelsi, H.; Bignon, J.; Lambre, C. 1992: U 937 cells are able to release a sialidase activity. FASEB Journal 6(5): A1615
Tobin, P.S. 1997: U S Environmental Protection Agency applications for Acute Exposure Guideline Levels. Abstracts of Papers American Chemical Society 214(1-2): CHAS 14
Schroder, L.J.; Beetem, W.A.; Claassen, H.C.; Emerson, R.L. 1973: U S Geological Survey, Denver, Colorado radiocarbon dates I. Radiocarbon 15(3): 469-478
Goosby, E.P.; Baitty, R.; Eichler, A.; Gomez, M.; Bowen, G.S.ephen 1993: U S government funding to improve access to HIV care for underserved urban populations Year two of the Ryan White Care Act. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 937
Boyce, J.W.; Hodges, K.V. 2005: U and Th zoning in Cerro de Mercado Durango, Mexico fluorapatite; insights regarding the impact of recoil redistribution of radiogenic super 4 He on U-Th/ He thermochronology. Chemical Geology 219(1-4): 261-274
Reiter, L.; Kruithof, E.; Sordat, B. 1992: U pa u par expression and the invasive phenotype in vitro behavior of u pa transfected human colon carcinoma ht29 cells. Experientia 48(ABSTR): A93
Botto, H. 1991: U shape detubularized ileal bladder camey ii developing some technics to make it easier. Journal of Urology 145(4 Suppl): 203A
Botto, H.; Herve, J.M.; Barre, P.; Thebaut, Y.; Butreau, M.; Caney, M. 1992: U shaped detubularized ileal bladder camey ii results in 105 patients. Scandinavian Journal of Urology and Nephrology Suppl (142): 165
Filipowicz, W.; Kiss, T.; Marshallsay, C.; Waibel, F. 1990: U small nuclear rna genes u small nuclear rna and u small nuclear rnps of higher plants. Molecular Biology Reports 14(2-3): 125-130
Takeda, Y.; Wise, K.S.; Grady, G.; Wang, G.; Sharp, G.C.; Hardin, J.A. 1996: U snRNP-associated F78 particle is not recognized by IgM autoantibodies to B-1/B polypeptides which immunoprecipitate only U1 snRNP. Arthritis and Rheumatism 39(9 Suppl): S182
Kim, K.J.; Baik Han, E.J.; Chung, J.M. 1989: U turn afferent fibers in the rat ventral root. Society for Neuroscience Abstracts 15(1): 103
Wernicke Rolf, S.; Lippolt Hans, J. 1997: U+Th-He evidence of Jurassic continuous hydrothermal activity in the Schwarzwald basement, Germany. Chemical Geology 138(3-4): 273-285
Piercey, M.F.; Hoffmann, W.E.; Hyslop, D.K.; Camacho Ochoa, M.; Saleem, A.; Broderick, P.A. 1996: U-101387G, a selective antagonist of dopamine D-4 receptors, alters mesocorticolimbic dopamine release without altering nerve impulse rate. Society for Neuroscience Abstracts 22(1-3): 1772
Batts, D.H.; Borin, M.T.; Peel, B.G.; Hanover, C.K.; Brewer, J.E.; Francom, S.F.; Dietz, A.J. 1996: U-103017 Phase I, multiple-dose, safety, tolerance, and pharmacokinetics of the oral disodium salt in healthy volunteers. INFECTIOUS DISEASES SOCIETY OF AMERICA , NATIONAL INSTITUTES OF HEALTH , CENTERS FOR DISEASE CONTROL AND PREVENTION 3rd Conference on retroviruses and opportunistic infections : 81
Tayvek, J.A.; Lee, W.N.P.; Katz, J.A. 1995: U-13C-lactate infusion in humans to estimate Krebs cycle parameters. Journal of Investigative Medicine 43(Suppl 2): 402A
Thompson, A.C.; Shippenberg, T.S.; Justice, J.B. 1997: U-69593, A selective kappa-opioid receptor agonist, increases the rate of dopamine uptake in the N accumbens and striatum. Society for Neuroscience Abstracts 23(1-2): 693
Martin, K.J.; Mcconkey, C.; Jacobs, A.; Gonzalez, E.; Baldassare, J.J. 1993: U-73122 An inhibitor of phospholipase C, dissociates the effect of parathyroid hormone stimulated kinase-A and kinase-C activities in opossum kidney cells. Journal of the American Society of Nephrology 4(3): 724
Liu, P.; Vonderfect, S.L.; Fisher, M.A.; Mcguire, G.M.; Farhood, A.; Jaeschke, H. 1994: U-74006F protects against endotoxin shock and acute liver failure in rats. FASEB Journal 8(4-5): A125
Yue, G.; Sun, F.F.; Wong, P.Y.K. 1993: U-74006F, an antioxidant lazaroid, accelerates the healing of inflammatory bowel disease in rat. Gastroenterology 104(4 Suppl): A806
Qian, X.B.; Leblanc, M.H.; Patel, D.M.; Huang, M.; Smith, P.J.S.V.g And, E.E. 1996: U-74389G does not affect the severity of hypoxic ischemic brain injury in the piglet. Journal of Investigative Medicine 44(1): 75A
Sutton, R.L. 1994: U-74389G treatments after cortical contusion in the rat. Society for Neuroscience Abstracts 20(1-2): 192
Altavilla, D.; Squadrito, F.; Canale, P.; Ioculano, M.; Squadrito, G.; Campo, G.M.; Caputi, A.P. 1996: U-83836E, a new lazaroid, inhibits tumor necrosis factor-alpha and protects against endotoxin shock. Fundamental and Clinical Pharmacology 10(2): 161
Barbachyn, M.R.; Hutchinson, D.K.; Toops, D.S.; Reid, R.J.; Zurenko, G.E.; Yagi, B.H.; Schaadt, R.D.; Allison, J.W. 1993: U-87947E, a potent quinolone antibacterial agent incorporating a bicyclo pent-1-yl subunit. Bioorganic and Medicinal Chemistry Letters 3(4): 671-676
Toombs, C.F.; Shebuski, R.J. 1994: U-89232 , a novel antiischemic agent derived from cromakalim. Cardiovascular Drug Reviews 12(4): 303-316
Schreur, P.J.K.D.; Nichols, N.F.; Stone, M.P. 1992: U-91356A A novel dopamine agonist with potential antiparkinsonian activity. Society for Neuroscience Abstracts 18(1-2): 1081
Piercey, M.F.; Moon, M.W.; Hoffmann, W.E.; Walters, R.; Blanchette, P.; Bedard, P. 1992: U-91356a, a potent, effective, orally active D2 agonist potentially useful in treating Parkinsons disease. Society for Neuroscience Abstracts 18(1-2): 1081
Takashima, M.; Liou, S.Y.; Kunihara, M. 1994: U-92032, a T-type Ca channel blocker and antioxidant, inhibited glutamate release evoked by hypoxia. Japanese Journal of Pharmacology 64(Suppl 1): 207P
Schreur, P.J.K.D.; Stone, M.P.; Nichols, N.F.; Lin, C.H.; Haadsma Svensson, S.R. 1993: U-93385 An orally active anxiolytic with selective 5-HT-1A agonist activity. Society for Neuroscience Abstracts 19(1-3): 1867
Piercey, M.F.; Svensson, K.A.; Lin, C.H.; Haadsma Svensson, S.R.; Mccall, R.B.; Smith, M.W.; Broderick, P.A.; Carlsson, A. 1993: U-93385, a high intrinsic activity 5-HT1A agonist with good oral activity. Society for Neuroscience Abstracts 19(1-3): 1866
Dillon, G.H.; Im, H.; Hamilton, B.J.; Carter, D.B.; Gammill, R.B.; Im, W.B. 1993: U-93631 causes rapid decay of GABA-induced Cl current in recombinant rat GABA-A receptors. Society for Neuroscience Abstracts 19(1-3): 852
Mene, P.; Fais, S.; Cinotti, G.A.; Pugliese, F.; Thierauch, K.H. 1995: U-937 monocytes bind to and stimulate proliferation of cultured human mesangial cells Regulation by cytokines and vasoactive agents. Kidney International 47(2): 660
Cinotti, G.A.; Pugliese, F.; Mene, P. 1996: U-937 monocytes promote apoptosis of human mesangial cells Modulation by serum and thromboxane A-2. Journal of the American Society of Nephrology 7(9): 1694
Sethy, V.H.; Ellerbrock, B.R.; Wu, H. 1995: U-95666A A potential anti-Parkinson drug. Society for Neuroscience Abstracts 21(1-3): 1254
Schreur, P.J.K.D.; Nichols, N.F. 1995: U-95666A, a dopamine D2 agonist Behavioral studies in rats. Society for Neuroscience Abstracts 21(1-3): 853
Sethy, V.H.; Wu, H. 1996: U-95666E A potential neuroprotective drug. Society for Neuroscience Abstracts 22(1-3): 2133
Mcmichael, A.; Walker, E.L.; Piercey, M.F. 1997: U-99194A, a D-3 receptor antagonist, antagonizes increases in brain energy metabolism evoked by the psychotomimetic phencyclidine Implications for antipsychotic therapy. Society for Neuroscience Abstracts 23(1-2): 1930
Walker, E.L.; Smith, M.W.; Schreur, P.J.K.D.; Fitch, C.S.; Piercey, M.F. 1995: U-99194A, a D-3 receptor antagonist, selectively abolishes amphetamines non-striatal increases in brain energy metabolism Implications for antipsychotic therapy. Society for Neuroscience Abstracts 21(1-3): 857
Sambrook, J.F.; Madison, E.L.; Goldsmith, E.J.; Gething, M.H.; Gerard, R.D. 1998: U-PA mutants resistant to inhibition by their cognate inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1208(3): 2323
D.B.rt, A.C.W.; Quax, P.H.A.; Schalken, J.H.; Verheijen, J.H. 1994: U-PA production and u-PA mediated extracellular matrix degradation by rat prostate cancer cells in vitro correlates with metastatic behaviour in vivo. Fibrinolysis 8(Suppl 1): 57
McDonough, M.R.; McNicoll, V.J. 1997: U-Pb age constraints on the timing of deposition of the Waugh Lake and Burntwood Athabasca groups, southern Taltson magmatic zone, northeastern Alberta. Current Research - Geological Survey of Canada: 101-111
Lin Shoufa; Davis Donald, W.; Barr Sandra, M.; van Staal Cees, R.; Chen Yadong; Constantin Marc 2007: U-Pb geochronological constraints on the evolution of the Aspy Terrane, Cape Breton Island; implications for relationships between Aspy and Bras dOr Terranes and Ganderia in the Canadian Appalachians. American Journal of Science 307(2): 371-398
Poller Ulrike; Todt Wolfgang 2000: U-Pb single zircon data of granitoids from the High Tatra Mountains Slovakia; implications for the geodynamic evolution. Transactions of the Royal Society of Edinburgh: Earth Sciences 91, Parts 1-2: 235-243
Parent Martin; Machado Nuno; Zwanzig Herman, V. 1999: U-Pb system in monazite and chronology of deformation and metamorphism of the metasedimentary rocks of the Kisseynew Domain, Trans-Hudson Orogen Manitoba, Canada. Canadian Journal of Earth Sciences 36(11): 1843-1857
Almeida, A.; Leterrier, J.; Noronha, F.; Bertrand, J.M. 1998: U-Pb zircon and monazite geochronology of the Hercynian two-mica granite composite pluton of Cabeceiras de Basto northern Portugal. Comptes Rendus de l'Academie des Sciences, Serie II Sciences de la Terre et des Planetes
Esumi, H.; Tannenbaum, S.R. 1994: U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis. Cancer Research 54(1): 297-301
Yang Junlong; Yu Bisheng 1997: U-Th-Pb geochronology and lead isotope geochemistry of the Laerma carlin-type gold deposit in the western Qinling Mountains. Huanan Dizhi Yu Kuangchan = Geology and Mineral Resources of South China 1997(4(52)): 39-49
Min Kyoungwon; Reiners Peter, W.; Wolff John, A.; Mundil Roland; Winters, R.L.e 2006: U-Th/ He dating of volcanic phenocrysts with high U-Th inclusions, Jemez volcanic field, New Mexico. Chemical Geology 227(3-4): 223-235
Tagami Takahiro; Farley Kenneth, A.; Stockli Daniel, F. 2003: U-Th/ He geochronology of single zircon grains of known Tertiary eruption age. Earth and Planetary Science Letters 207(1-4): 57-67
Spikings, R.A.; Crowhurst, P.V. 2004: U-Th/ He thermochronometric constraints on the late Miocene-Pliocene tectonic development of the northern Cordillera Real and the Interandean Depression, Ecuador. Journal of South American Earth Sciences 17(4): 239-251
Herman Frederic; Braun Jean; Senden Tim, J.; Dunlap William, J. 2007: U-Th/ He thermochronometry; mapping 3D geometry using micro-X-ray tomography and solving the associated production-diffusion equation. Chemical Geology 242(1-2): 126-136
Reiners Peter, W.; Campbell, I.H.; Nicolescu, S.; Allen, C.M.; Hourigan, J.K.; Garver, J.I.; Mattinson, J.M.; Cowan, D.S. 2005: U-Th/ He-Pb double dating of detrital zircons. American Journal of Science 305(4): 259-311
Gautheron, C.E.; Tassan Got, L.; Farley, K.A. 2006: U-Th/ Ne chronometry. Earth and Planetary Science Letters 243(3-4): 520-535
Mitchell, J.J.; Vekemans, M.; Luscombe, S.; Hayden, M.; Weber, B.; Richter, A.; Sparkes, R.; Kojis, T.; Watters, G.; Der Kaloustian, V.M. 1994: U-type exchange in a paracentric inversion as a possible mechanism of origin of an inverted tandem duplication of chromosome 8. American Journal of Medical Genetics 49(4): 384-387
Lordereau Richard, I.; Georges, P.; Chaussain, J.L. 1993: U-hGH assay in Laron dwarfism. Pediatric Research 33(5 Suppl): S38
D.N.cola, L.; Georges, P.; Chaussain, J.L. 1998: U-hGH profile in normal subjects in growth retardation patients. Hormone Research (Basel) 50(Suppl 3): 137
Hadad, K.; Doulatdar, R. 2008: U-series concentration in surface and ground water resources of Ardabil province. Radiation Protection Dosimetry 130(3): 309-318
Burnett, W.C.; Glenn Craig, R.; Yeh, C.C.; Schultz, M.; Chanton, J.; Kashgarian, M. 2000: U-series, super 14 C, and stable isotope studies of Recent phosphatic protocrusts from the Peru margin. Special Publication - Society for Sedimentary Geology 66: 163-183
Kabakov, A.Y. 1995: U-shaped dependence of membrane potential on Na+-K+ pump activity. Biophysical Journal 68(2 Part 2): A231
Bae, O.-N.; Lim, K.-M.; Han, J.-Y.; Jung, B.-I.; Lee, J.-Y.; Noh, J.-Y.; Chung, S.-M.; Lee, M.-Y.; Lee, J.-Y.; Chung, J.-H. 2008: U-shaped dose response in vasomotor tone: a mixed result of heterogenic response of multiple cells to xenobiotics. Toxicological Sciences: An Official Journal of the Society of Toxicology 103(1): 181-190
Main, M.J.; Cannell, M.B. 1996: U-shaped inactivation curves recorded with Ba-2+ as the charge carrier through L-type calcium channels in isolated guinea-pig ventricular myocytes. Journal of Physiology (Cambridge) 497P: 127P-128P
Power, C.; Rodgers, B.; Hope, S. 1998: U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality. Lancet 352(9131): 877
Bormann, J. 1992: U-tube drug application. Kettenmann, H, Grantyn, R Practical electrophysiological methods: A guide for in vitro studies in vertebrate neurobiology: 136-140
Hrasko, L. ubomir; Hatar Jozef; Huhma Hannu; Mantari Irmeli; Michalko Juraj; Vaasjoki Matti 1999: U/ Pb zircon dating of the Upper Cretaceous granite Rochovce type in the Western Carpathians. Krystalinikum 25: 163-171
Quinif, Y.; Bastin, B. 1994: U/Th dating and pollen analysis of a stalagmitic sequence of the isotopic stage 5. Comptes Rendus de l'Academie des Sciences Serie II Sciences de la Terre et des Planetes 318(2): 211-217
Vaux, P.; Waugh, R.; Brown, J.W.S. 1991: U1 and u2 small nuclear rnps in potato. Journal of Experimental Botany 42(238 Suppl): 36
L.X.; Rekosh, D.; Hammarskjold M L. 1990: U1 rna plays a role in the processing of rev dependent unspliced hiv1 env messenger rna. Journal of Cellular Biochemistry Suppl (14 Part D): 106
Rosbash, M.; Abovich, N.; Colot, H.V.; Goguel, V.; Liao, X. 1991: U1 small nuclear rnp and splice site choice in saccharomyces cerevisiae. Journal of Cellular Biochemistry Suppl (15 Part D): 46
Song, Y.; Zamrod, Z.; Stumph, W.E. 1993: U1 snRNA transcription is dependent upon the TATA-binding protein and two proximal motifs with a stringent spacing requirement. FASEB Journal 7(7): A1221
Morris, P.W.; Stetler, D.A. 1992: U1 snrna is required for rna polymerase i transcriptional activity. Biophysical Journal 61(2 Part 2): A73
Heinrichs, V.; Bach, M.; Luehrman, R. 1990: U1 specific protein c is required for efficient complex formation of u1 small nuclear rnp with a 5 splice site. Molecular Biology Reports 14(2-3): 165-166
Basu, M.K.; Makalowski, W.; Rogozin, I.B.; Koonin, E.V. 2008: U12 intron positions are more strongly conserved between animals and plants than U2 intron positions. Biology Direct 3: 19
Byers, D.M.; Carter, J.M.; Sparrow, S.M.; Cook, H.W.; Ridgway, N.D. 1997: U18666A inhibits regulation of intracellular cholesterol metabolism and neurotransmitter release in human neuroblastoma cells. FASEB Journal 11(9): A1097
Dugan, E.M.; Tunnessen, W.W.; Honig, P.J.; Watson, R.M. 1992: U1rnp neonatal lupus erythematosus a report of two cases with immunogenetic studies. Clinical Research 40(2): 271A
Pederson, T.; Kleinschmidt, A. 1990: U2 rna processing and small nuclear rnp assembly studied in vivo by rna transfection. Molecular Biology Reports 14(2-3): 179-`80
Temsamani, J.; Pederson, T. 1990: U2 small nuclear rnp associates with nuclear factors small nuclear after cytoplasmic assembly in a reaction requiring atp and the u2 small nuclear rnp specific a and b proteins. Journal of Cell Biology 111(5 Part 2): 246A
Organ, E.; Ruley, E.; Rubin, D.H. 1996: U3 gene-trap retrovirus selection of cellular mutants resistant to lytic reovirus infection. Journal of Investigative Medicine 44(3): 320A
Jacobson, M.R.; Pederson, T. 1996: U3 small nuclear RNA localizes in the nucleolus via a cap-dependent mechanism. Molecular Biology of the Cell 7(Suppl ): 106A
Glibetic, M.; Larson, D.E.; Sienna, N.; Sells, B.H. 1990: U3 small nuclear rna expression is repressed during a down shift in ribosomal rna synthesis. Journal of Cell Biology 111(5 Part 2): 247A
Withrington P.G.; Antunes E.; Grassi Kassisse D.M.; De Nucci G. 1992: U46619 a stable thromboxane mimetic can constrict the canine splenic arterial vasculature without significant effect on capsular smooth muscle. British Journal of Pharmacology 105(Proceedings Suppl APRIL): 306P
Perez Vizcaino, F.; Villamor, E.; Del Pozo, F.F.; Fernandez, C.; Tamargo, J. 1997: U46619 and endothelin-1 inhibit the relaxant responses via cGMP pathway in piglet pulmonary arteries. British Journal of Pharmacology 120(Proceedings Suppl ): 149P
Maisonneuve, I.M.; Glick, S.D. 1994: U50,488, A Kappa agonist, attenuates cocaine-induced increases in extracellular dopamine in nucleus accumbens. Society for Neuroscience Abstracts 20(1-2): 1634
Hubbell, C.L.; Barringer, T.M.; Gonzales, P.M.; Moran, C.M.; Reid, L.D. 1996: U50,488, a kappa opioid agonist, and cocaines reward-relevant effects. Society for Neuroscience Abstracts 22(1-3): 703
Carden, S.E.; Bortot, A.T.; Hofer, M.A. 1992: U50488 and pentylenetetrazole, but not naltrexone, elicit ultrasonic vocalizations from rat pups in the homecage. Society for Neuroscience Abstracts 18(1-2): 659
Widmayer, M.A.; Browning, J.L.; Baskin, D.S. 1992: U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia. Society for Neuroscience Abstracts 18(1-2): 1255
Patterson, A.B.; Holtzman, S.G. 1996: U69,593, a K-opioid receptor agonist, potentiates the antinociceptive effects of cocaine in the hot-plate assay. Society for Neuroscience Abstracts 22(1-3): 1684
Gray, A.M.; Mcginty, J.F. 1997: U69,593, a kappa opioid receptor agonist, decreases amphetamine-evoked extracellular dopamine levels in the nucleus accumbens of conscious rats. Society for Neuroscience Abstracts 23(1-2): 2145
Grierson, J.P.; Meldolesi, J. 1993: U73122, a phospholipase C inhibitor, alters Ca-2+ homeostasis in PC12 and fibroblast cells. Society for Neuroscience Abstracts 19(1-3): 751
Kong, Y.; Ye, J.; Lesnefsky, E.J.; Horwitz, L.D. 1993: U74006F prevents myocardial lipid preoxidation and reduces ventricular dysfunction due to iron-catalyzed oxygen free radical reactions. FASEB Journal 7(3-4): A102
Bergeron, Y.; Morin, N.J.; Cantin, M.F.; Bergeron, M.G. 1993: U74389F, a new 21-aminosteroid, as antioxidant therapy in a rat model of endotoxemic shock. Clinical and Investigative Medicine 16(4 Suppl): B79
Duguay, P.; Chen, H.F.; Daloze, P.; Senechal, J.; Dumont, L. 1995: U74389G, A 21-aminosteroid inhibitor of lipid peroxidation, affords significant cardioprotection following prolonged hypothermic storage and transplantation of rat hearts. FASEB Journal 9(4): A894
Hays, A.M.; Lantz, R.C.; Vermuelen, M.; Chen, G.; Witten, M.L. 1993: U75412E pretreatment before acute smoke exposure causes a large increase in lung prostacyclin concentrations. FASEB Journal 7(3-4): A507
Figueroa, J.T.; Liebler, D.C.; Hays, A.M.; Lantz, R.C.; Vermuelen, M.; Chen, G.; Witten, M.L. 1993: U75412E pretreatment before acute smoke exposure increases BAL vitamin E levels. FASEB Journal 7(3-4): A408
Gaetani, P.; Marzatico, F.; Cafe, C.; Messina, A.L.; Rodriguez, Y.Baena, R. 1993: U78517F treatment after experimental SAH Effects on lipid peroxidative patterns in synaptosomal cortical preparations. Canadian Journal of Neurological Sciences 20(Suppl 1): S29
Peculis, B.A. 1995: U8 and U14 snoRNAS are essential for pre-rRNA processing in vertebrates. Molecular Biology of the Cell 6(Suppl ): 195A
Nolfo, R.; Rankin, J.A. 1989: U937 and thp 1 cells do not release ltb4 ltc4 or ltd4 in response to a 23187. American Review of Respiratory Disease 139(4 Part 2): A93
Mitchell, F.M.; Milligan, G. 1991: U937 cell differentiation: G protein alterations and interaction with the chemotactic peptide receptor. Biochemical Society Transactions 19(2): 98s
Li, Y.; Aarons, R.; Hilliard, L.; Howard, T. 1996: U937 cell motility is modulated by level of leufactin The actin binding protein overexpressed in NAD 47/89, a defect of human neutrophil motility. Blood 88(10 Suppl 1 Part 1-2): 155A
Koehler, L.; Nettelnbrecker, E.; Holtmann, H.; Zeidler, H. 1993: U937 cells as a model for infection of monocytic cells with Chlamydia trachomatis. Immunobiology 189(1-2): 179
Stoolman, L.M.; Abassi, O.; Craig, R. 1994: U937 cells use both E-selectin and alpha-4-containing integrins to initiate contact with cytokine-treated endothelium under shear-stress. FASEB Journal 8(4-5): A894
Jobe, C.D.; Parmely, M.J. 1992: U937 promonocytic cells inactivate the bioactivity of interferon gamma by direct plasmin proteolysis. FASEB Journal 6(4): A1329
Lajiness, M.E.; Chio, C.L.; Schreur, P.J.K.D.; Huff, R.M. 1996: U95666A is a high intrinsic activity agonist with selectivity for the D2 dopamine receptor. Society for Neuroscience Abstracts 22(1-3): 217
Muccio, D.D.; Brouillette, W.J. 1998: UAB retinoids in chemoprevention and leukemia therapy. Abstracts of Papers American Chemical Society 216(1-3): MEDI 376
Worgul, B.V.; Likhtaryov, I.; Kundiev, Y.; Medvedovsky, C.; Sergienko, N.; Wu, B.; Parkhomenko, G.; Chumak, B.; Ruban, A. 1994: UACOS A Ukrainian American Chernobyl Ocular Study. IOVS Investigative Ophthalmology and Visual Science: 35(4)
Nass, A.; Schuell, C.; Grimm, M.; Beier, H. 1994: UAG readthrough during translation of carnation mottle virus RNA. Biological Chemistry Hoppe-Seyler 375(SPEC Suppl 1): S76
Sharples, C.G.; Kaiser, S.A.; Mogg, A.J.; Wright, E.; Gallagher, T.; Wonnacott, S. 1998: UB-165 A novel epibatidine-anatoix-a hybrid that is a nicotinic agonist with subtype selectivity. Society for Neuroscience Abstracts 24(1-2): 86
Sanchez Carbayo, M.; Megias, J.; Molina, R.; Mira, A.; Filella, X.; Ballesta, A.; Soria, F. 1998: UBC rapid test as a new tumor marker in the diagnosis of bladder cancer. Tumor Biology 19(Suppl 2): 72
Robinson, M. 1996: UBC researcher's back-pain studies focus on space travel. Cmaj: Canadian Medical Association Journal 154(1): 94-95
Sanchez Carbayo, M.; Megias, J.; Molina, R.; Mira, A.; Filella, X.; Ballesta, A.; Soria, F. 1998: UBC, a new tumor marker in the diagnosis of bladder cancer. Tumor Biology 19(Suppl 2): 72
Bandman, O.; Goli, S.K. 1998: UBCH7-like ubiquitin-conjugating enzyme. Official Gazette of the United States Patent and Trademark Office Patents 1217(2): 1650
Buerger, J.; Hennies, H.C.; Sperling, K.; Reis, A. 1998: UBE3A gene expression in Angelman syndrome patients with imprinting defects. European Journal of Human Genetics 6(Suppl 1): 140
Kishino, T.; Lalande, M.; Wagstaff, J. 1997: UBE3A/E6-AP mutations in Angelman syndrome indicate a role for the ubiquitin pathway in brain development. American Journal of Human Genetics 61(4 Suppl): A39
Pikaard, C.S.; Copenhaver, G.P.; Putnam, C.D.; Denton, M.L. 1994: UBF-nucleic acid interactions and the molecular evolution of ribosomal gene enhancers. Journal of Cellular Biochemistry Suppl 1994(18C): 69
Luo, M.; Luo, M.-Z.; Buzas, D.; Finnegan, J.; Helliwell, C.; Dennis, E.S.; Peacock, W.J.; Chaudhury, A. 2008: UBIQUITIN-SPECIFIC PROTEASE 26 is required for seed development and the repression of PHERES1 in Arabidopsis. Genetics 180(1): 229-236
Lung, E.; Schilling, M.; Steuhl, K.P.; Wessing, A. 1997: UBM in comparison with standardized A-scan/B-scan echography in melanomas of the peripheral UVEA and ciliary body A pilot study. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S1070
Kuhn Emil 1946: UBeta er Acrodus-Funde aus dem Grenzbitumenhorizont der anisischen Stufe der Trias des Monte San Giorgio Kt Tessin. Eclogae Geologicae Helvetiae 38(2): 662-673
Wang, F.; Li, X.; Xie, X.; Zhao, L.; Chen, W. 2008: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. Febs Letters 582(13): 1919-1927
Takahashi, I.; Maruta, R.; Ando, K.; Yoshida, M.; Iwasaki, T.; Kanazawa, J.; Okabe, M.; Tamaoki, T. 1993: UCA1064-B, a new antitumor antibiotic isolated from Wallemia sebi: production, isolation and structural determination. Journal of Antibiotics 46(8): 1312-1314
Fujii, N.; Yamashita, Y.; Ando, K.; Agatsuma, T.; Saitoh, Y.; Gomi, K.; Nishiie, Y.; Nakano, H. 1994: UCE1022, a new antitumor antibiotic with topoisomerase i mediated DNA cleavage activity, from Paecilomyces. Journal of Antibiotics 47(8): 949-951
Fujii, N.; Yamashita, Y.; Chiba, S.; Uosaki, Y.; Saitoh, Y.; Tuji, Y.; Nakano, H. 1993: UCE6, a new antitumor antibiotic with topoisomerase i mediated DNA cleavage activity, from actinomycetes. Journal of Antibiotics 46(7): 1173-1174
Nakano, H.; Hara, M.; Akasaka, K.; Akinaga, S.; Okabe, M.; Gomez, R.; Wood, D.; Uh, M.; Tamanoi, F. 1993: UCF1, protein farnesyltransferase inhibitors from Streptomyces Antitumor activity in murine tumors models with activated ras. Proceedings of the American Association for Cancer Research Annual Meeting 34: 386
Nagase, T.; Kawata, S.; Yamazaki, E.; Ishiguro, H.; Matuzawa, Y. 1993: UCF1-C potently inhibits growth of Hep G2 cells by suppressing protein farnesyltransferase activity. Hepatology 18(4 Part 2): 190A
Carpenter, P.M.; Gamboa-Vujicic, G.; Mascarello, J.T.; Wilczynski, S.; Bhaumik, M.; Dorion, G.; Manetta, A. 1995: UCI-VULV-1, a vulvar squamous carcinoma cell line. Gynecologic Oncology 57(2): 191-198
Mizukami, T.; Asai, A.; Yamashita, Y.; Katahira, R.; Hasegawa, A.; Ochiai, K.; Akinaga, S. 1997: UCK14 compounds. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 478
D.L.Colbern, Et@al 1995: UCLA Kids Judge Neuroscience Fair. Society for Neuroscience Abstracts 21(1-3): 250
Light, R.; Asarnow, R.F.; Satz, P.; Zaucha, K.; Lewis, R. 1993: UCLA studies of mild closed-head injury III Behavioral and academic outcomes. Journal of Clinical and Experimental Neuropsychology 15(1): 20-21
Grever, M.R.; Shinn, C.; Levy, J. 1995: UCN-01 A new potential therapeutic agent for chronic lymphocytic leukemia. Blood 86(10 Suppl 1): 349A
Byrd, J.C.; Shinn, C.A.; Bedi, A.; Waselenko, J.K.; Flinn, I.W.; Diehl, L.F.; Sausville, E.; Grever, M.R. 1997: UCN-01 A promising new agent for B-cell chronic lymphocytic leukemia that induces apoptosis independent of p53 status. Blood 90(10 Suppl 1 Pt 2): 306B
Husain, A.; Rosales, N.; Schwartz, G.K.; Spriggs, D.R. 1997: UCN-01 enhances CDDP cytotoxicity in ovarian cancer cells independent of p53 gene status and abrogation of G2 block. Proceedings of the American Association for Cancer Research Annual Meeting 38: 321
Shinn, C.A.; Byrd, J.C.; Waselenko, J.K.; Sausville, E.; Miller, C.; Gore, S.; Grever, M.R. 1997: UCN-01 has significant in vitro activity in both the resistant K562 cell line and human acute leukemia cells. Blood 90(10 Suppl 1 Pt 2): 246B
Mack, P.C.; Edelman, M.J.; Gandara, D.R.; Gumerlock, P.H. 1998: UCN-01 synergizes with cisplatin in non-small cell lung carcinoma cell lines with wild-type and mutant RB and p53. Journal of Investigative Medicine 46(1): 126A
Kruger, E.A.; Blagosklonny, M.V.; Dixon, S.C.; Figg, W.D. 2000: UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response. Invasion and Metastasis 18(4): 209-218
Pollack, I.F.; Kawecki, S.; Rusnak, J.M.; Lazo, J.S. 1996: UCN-01, a selective protein kinase C inhibitor, blocks glioma proliferation and induces apoptosis in vitro and inhibits glioma growth in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 37: 424
Yu, L.; Orlandi, L.; Wang, P.; Krawchuk, D.; Rucker, K.; O'connor, P.M. 1998: UCN-01-induced G2 checkpoint abrogation requires a functional Cdc2 kinase and is associated with inactivation of the Wee1 kinase. Proceedings of the American Association for Cancer Research Annual Meeting 39: 178
Saito, M.; Irie, Y.; Asano, A.; Nikami, H.; Kimura, K. 1998: UCP expression in immortal brown adipocytes isolated from p53-deficient mice. International Journal of Obesity 22(Suppl 3): S14
Davis, L.M.; Rho, J.M.; Sullivan, P.G. 2008: UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia 49(Suppl 8): 117-119
Boss, O.; Bobbioni Harsch, E.; Assimacopoulos Jeannet, F.; Muzzin, P.; Muenger, R.; Giacobino, J.P.; Golay, A. 1998: UCP3 expression in skeletal muscle and free fatty acids in obese humans. International Journal of Obesity 22(Suppl 3): S60
D.J.ng, P.J.; Merckelbach, H.; Koertshuis, G.; Muris, P. 1994: UCS-inflation and acquired fear responses in human conditioning. Advances in Behaviour Research and Therapy 16(3): 131-165
Mizukami, T.; Ogawa, H.; Nakai, R.; Asai, A.; Yamashita, Y.; Ando, K.; Agatsuma, T.; Akinaga, S.; Ouchi, K.; Kawasaki, H. 1998: UCS1025 compounds. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3740-3741
Kneller, D.G.; Kuntz, I.D. 1993: UCSF Sparky An NMR display, annotation and assignment tool. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 254
Day, M.R.; Kuntz, I.D. 1993: UCSF Striker An interactive processing tool for multi-dimensional NMR data. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 251
Kanatakis, S.; Koutsis, D.; Aggelou, A.; Moussionis, A.; Dritsas, S. 1998: UDCA Alternative treatment in distinct categories of patients with chronic hepatitis C. Journal of Hepatology 28(Suppl 1): 208
Mazzella, G.; Salzetta, A.; Morelli, M.C.; Novelli, V.; Festi, D.; Polifemo, A.M.; Cipolla, A.; Roda, E. 1993: UDCA as adjuvant therapy in patients not responding to interferon treatment. Journal of Hepatology 18(Suppl 1): S52
Yan, C.C.; Bellentani, S.; Tiribelli, C.; Manenti, F. 1993: UDCA, TUDCA and taurine chronic oral administration changes total lipids content and fatty acids composition of hepatic microsomes in the rat. Journal of Hepatology 18(Suppl 1): S188
Zeniya, M.; Watanabe, F.; Urano, Y.; Kato, A.; Toda, G. 1996: UDCA-Equivalent increase in bilirubin secretion by folinic acid on cholestasis. Hepatology 24(4 Part 2): 216A
Oyaizu, M.; Sato, R.; Kasugai, H.; Saito, M.; Narahashi, T. 1997: UDCG-212, a new positive inotropic agent, blocks inwardly rectifying K+ channel in human ventricular myocytes. Biophysical Journal 72(2 Part 2): A253
Schulze Lohoff, E.; Hugo, C.; Rost, S.; Chang, K.; Takuwa, Y.; Ogilvie, A.; Sterzel, R.B. 1997: UDP increases intracellular calcium, c-fos expression and DNA synthesis in mesangial cells via specific UDP receptors. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 407A
Fricks, I.P.; Maddileti, S.; Carter, R.L.; Lazarowski, E.R.; Nicholas, R.A.; Jacobson, K.A.; Harden, T.K. 2008: UDP is a competitive antagonist at the human P2Y14 receptor. Journal of Pharmacology and Experimental Therapeutics 325(2): 588-594
Chapeau, M.C.; Frey, P.A. 1994: UDP-4-deoxy-fluoro glycosides Synthesis and study with UDP-galactose-4-epimerase. Abstracts of Papers American Chemical Society 208(1-2): CARB 21
Kariya, M.; Namiki, H. 1995: UDP-4ketoglucosamine as a reducing factor. Zoological Science 12(Suppl ): 48
Trombetta, S.; Sousa, M.; Parodi, A.J. 1993: UDP-GLC Glycoprotein glucosyltransferase, its possible involvement in glycoprotein folding. Molecular Biology of the Cell 4(Suppl ): 229A
Roth, J. 1997: UDP-GlcGlycoprotein glucosyltransferase is present in the ER and the intermediate compartment. Glycoconjugate Journal 14(6): 756
D.S.aso, S.; Visconti, U.; Balestrazzi, E. 1995: UDP-Glucose dehydrogenase activity and lactate production in normal and glaucomatous human trabecular meshwork cells. IOVS Investigative Ophthalmology and Visual Science 36(4): S728
Banhegyi, G.; Braun, L.; Marcolongo, P.; Fulceri, R.; Csala, M.; Mandl, J.; Benedetti, A. 1995: UDP-Glucuronic Acid-phenol glucuronide antiport in rat liver microsomal vesicles. Journal of Hepatology 23(Suppl 1): 163
Majumdar, S.; Bhattacharjee, H.; Bhattacharyya, D.; Bhaduri, A. 1998: UDP-galactose 4-epimerase from Kluyveromyces fragilis: reconstitution of holoenzyme structure after dissociation with parachloromercuribenzoate. European Journal of Biochemistry 257(2): 427-433
Ohta, H.; Shimojima, M.; Arai, T.; Masuda, T.; Shioi, Y.; Takamiya, K.I.hiro 1995: UDP-galactose Diacylglycerol galactosyltransferase in cucumber seedlings Purification of the enzyme and the activation by phosphatidic acid. Kader, J -C , Mazliak, P Plant lipid metabolism 152-155
Alano, A.; Almashanu, S.; Maceratesi, P.; Reichardt, J.; Panny, S.; Cowan, T.M. 1997: UDP-galactose-4-epimerase deficiency among African Americans Evidence for multiple alleles. Journal of Investigative Medicine 45(1): 191A
Popko, B.; Coetzee, T.; Dupree, J.; Fujita, N.; Suzuki, K.; Suzuki, K. 1997: UDP-galactoseceramide galactosyltransferase Molecular and functional analysis. Journal of Neurochemistry 69(Suppl ): S95
Barreiro, R.; Cheeseman, J. 1995: UDP-glucose dehydrogenase and the mechanism of carbon partitioning during cell growth. Plant Physiology (Rockville) 108(2 Suppl): 55
Zimmermann, A.; Blaszkewicz, M.; Roth, G.; Seidel, T.; Dietrich, H.; Schutschkow, O.; Bolt, H.M.; Golka, K. 2008: UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases. Journal of Toxicology and Environmental Health. Part A 71(13-14): 911-914
Prentice, D.A.; Mashford, M.L.; Desmond, P.V. 1997: UDP-glucuronosyltransferase isoform messenger RNA levels in bild duct ligated rats. Gastroenterology 112(4 Suppl): A1362
Nishiyama, T.; Ohnuma, T.; Inoue, Y.; Kishi, T.; Ogura, K.; Hiratsuka, A. 2008: UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation. Biochemical and Biophysical Research Communications 371(2): 247-250
Bock, K.W. 1994: UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. Advances in Pharmacology 27: 367-383
Tukey, R.H.; Nguyen, N.; Straub, P.; Lamb, G.; Durazzo, M.; Philipp, T.; Manns, M. 1994: UDP-glucuronosyltransferases are epitopes for LKM-3 autoantibodies in chronic hepatitis D. FASEB Journal 8(7): A1468
Conner, C.E.; Burchell, B.; Hume, R. 1997: UDP-glucuronyl transferase enzyme family in both human and Balb/c mouse lung. Biochemical Society Transactions 25(2): 181s
Conner, C.E.; Burchell, B.; Hume, R. 1996: UDP-glucuronyl transferase enzyme system in both human and BALB/c mouse lung. Immunology 89(Suppl 1): 36
Kane, A.S.; Kahng, M.W.; Reimschuessel, R.; Nhamburo, P.T.; Lipsky, M.M. 1994: UDP-glucuronyltransferase kinetics for 3-trifluoromethyl-4-nitrophenol in fish. Transactions of the American Fisheries Society 123(2): 217-222
Zeng,W.; Chatterjee,M.; Faik,A. 2008: UDP-xylose-stimulated glucuronyltransferase activity in wheat microsomal membranes characterization and role in glucurono xylan biosynthesis. Plant Physiology 7(1): 78-91
Stolfi, R.L. 1996: UDPG as a recue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU. Official Gazette of the United States Patent and Trademark Office Patents 1183(4): 2222
Stolfi, R.L. 1996: UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without bau. Official Gazette of the United States Patent and Trademark Office Patents 1189(1): 425
Sheen, Y.Y.; Owens, I.S.; Kim, S.S.; Kim, J.E. 1998: UDPGT cDNA expression and UDPGT1 in human liver. Journal of Toxicological Sciences 23(Suppl 2): 136-139
Berthelsen, J.; Consalez, G.G.; Viggiano, L.; Rocchi, M.; Blasi, F. 1997: UEF3-p64 gene, encoding a new homeo-protein binding PBX1, maps in the distal region of 21q. Cytogenetics and Cell Genetics 79(1-2): 41
Li, Q.; Castell, J.A.; Castell, D.O. 1993: UES relaxation and prepharyngeal pressure in response to the change of bolus size and consistency. Gastroenterology 104(4 Suppl): A542
Jacangelo, J.G.; Laine, J.M.; Cummings, E.W.; Adham, S.S. 1995: UF with pretreatment for removing DBP precursors. Journal - American Water Works Association 87(3): 100-112
Kizaki, M.; Takayama, N.; Matsushita, H.; Ikeda, Y. 1996: UF-1, a novel retinoic acid-resistant cell line established from a patient with acute promyelocytic leukemia. Proceedings of the American Association for Cancer Research Annual Meeting 37: 501
Deng,Z.N.; Harbaugh,B.K.; Peres,N.A. 2008: UF-331 and UF-340 new dwarf caladium cultivars for landscape and pot plants. HortScience 7: 2231-2235
Deng,Z.N.; Harbaugh,B.K.; Peres,N.A. 2008: UF-404 - dwarf, red caladium for container-forcing and sunny landscapes. HortScience 43(6)
Samach, A.; Kohalmi, S.; Haughn, G.; Crosby, W. 1997: UFO encounters of a floral kind. Plant Physiology (Rockville) 114(3 Suppl): 60
Kim, H.H.; Tam, J.W.; Chan, K.L. 1995: UFO in atria and pulmonary veins Is it a real phenomenon?. Circulation 92(8): I538
Coleman, T.J.; Schlotter, W.K.I.; Coleman, P.A.; Schlotter, A.M. 1997: UFO pop. Official Gazette of the United States Patent and Trademark Office Patents 1203(2): 1263
González Barón, M.; Feliu, J.; Garcia Girón, C.; Espinosa, J.; Martinez, B.; Blanco, E.; Crespo, M.C.; Ordóñez, A.; Espinosa, E.; de Castro, J.; Juárez, F.; Colmenarejo, A. 1997: UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience. Oncology 54(Suppl): 24-29
Hatfield, D.; Diamond, A. 1993: UGA: a split personality in the universal genetic code. Trends in Genetics: Tig 9(3): 69-70
Hu, P.Y.; Ernst, A.R.; Sly, W.S. 1992: UGA suppression of Hispanic Mutation for CA II deficiency syndrome suggests novel mechanism for genetic heterogeneity. American Journal of Human Genetics 51(4 Suppl): A29
A.A.si, M.T.; Genta, R.M.; Karttunen, T.J.; Graham, D.Y. 1995: UGI bleeding and gastric ulcer location are independent clues to NSAID use in patients with peptic ulcer regardless of H pylori status. Gut 37(Suppl 1): A89
Walker, R.; Cornelissen, G.; Haus, E.; Zaslavskaya, R.M.; Halberg, E.; Halberg, F. 1994: UGP for diagnosis of ovarian cancer and chronobiology. Proceedings of the American Association for Cancer Research Annual Meeting 35: 204
Monaghan, G.; Foster, B.; Jurima-Romet, M.; Hume, R.; Burchell, B. 1997: UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics 7(2): 153-156
Iolascon, A.; Faienza, M.F.; Giordani, L.; Perrotta, S.; Meloni, M.F.; Guggiu, G.; Miraglia Del Giudice, E. 1998: UGT1A promoter polymorphism differently contributes to jaundice in inherited hemolytic anemias of newborn. European Journal of Human Genetics 6(Suppl 1): 130-131
Limenta, L.M.G.; Jirasomprasert, T.; Tankanitlert, J.; Svasti, S.; Wilairat, P.; Chantharaksri, U.; Fucharoen, S.; Morales, N.P. 2008: UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers. British Journal of Clinical Pharmacology 65(6): 908-916
Franklin, M.R.; Nguyen, N.T.; Tukey, R.H. 1993: UGT2C1 The first of a new subfamily of UDP-glucuronosyltransferases identified from a rabbit liver cDNA library. FASEB Journal 7(7): A1202
Orel, V.E.; Danko, M.I.; Dzyatkovskaya, N.M. 1997: UHF inductive hyperthermia of mechanochemically activated sodium chloride. Dopovidi Natsional'noyi Akademiyi Nauk Ukrayiny 1997(7): 185-187
Clay, T.M.; Culpan, D.; Howell, W.M.; Sage, D.A.; Bidwell, J.L.; Bradley, B.A. 1994: UHG crossmatching A novel approach to selecting HLA-DPB1 compatible donors for BMT. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 158
Clay, T.; Culpan, D.; Howell, W.M.; Sage, D.; Bidwell, J.; Bradley, B.A. 1994: UHG crossmatching for the selection of HLA-DPB1 compatible bone marrow donors. Human Immunology 39(2): 150
Neaves, P. 1995: UHT plant cleaning Problems and solutions. International Biodeterioration and Biodegradation 36(3-4): 461-462
Burger, M.M.; Moses, H.L. 1997: UICC Study Group on Basic and Clinical Cancer Research: mechanisms of growth factor and hormone insensitivity. International Journal of Cancer 73(4): 461-463
Burger, M.M.; Harlow, E. 1995: UICC Study group on basic and clinical cancer research Cell-cycle control A target for therapy?. International Journal of Cancer 63(3): 321-323
Oommen, P.T.; Romahn, A.; Linden, T.; Frühwald, M.C.; Bucsky, P. 2008: UICC-2002 TNM classification is not suitable for differentiated thyroid cancer in children and adolescents. Pediatric Blood and Cancer 50(6): 1159-1162
Jackson, C.; Best, N.; Elliott, P. 2008: UK Biobank Pilot Study: stability of haematological and clinical chemistry analytes. International Journal of Epidemiology 37(Suppl 1): I16-I22
Phillips, C.P.; Court, D.S.; Tamaki, N. 1998: UK Caucasian databases for the short tandem repeat loci D21S11, HUMFIBRA and D8S1179. Olaisen, B, Brinkmann, B, Lincoln, P J International Congress Series; Progress in Forensic Genetics, 7 398-400
Arlett, P.R.; Lee, E.H.; Cave, A.C.; Hooker, M.; Darbyshire, J.H.; Breckenridge, A.M.; Rawlins, M. 1998: UK HIV adverse drug reactions reporting scheme. AIDS 12(Suppl 4): S55
Allan, N.; Richards, S.; Shepherd, P. 1994: UK MRC randomised trial of interferon-alpha in chronic phase chronic myeloid leukaemia. British Journal of Haematology 87(Suppl 1): 164
Mccoll, K.E.L.; Murray, L.S.; El Omar, E.; Kelman, A.W.; Dickson, A.; El Nujumi, A.; Wirz, A.; Knill Jones, R.; Penney, C.; Cochrane, K.; Danesh, B.; Gaw, N.; Wilson, F. 1998: UK MRC trial of H pylori eradication therapy for non-ulcer dyspepsia. Gastroenterology 114(4 Part 2): A222
Anonymous 1982: UK Minerals in 81. Industrial Minerals (London) 179): 17
Jennings, I.; Woods, T.A.L.; Kitchen, S.; Preston, F.E. 1996: UK NEQAS for blood coagulation Detection of the lupus anticoagulant. British Journal of Haematology 93(Suppl 2): 316-317
Miller, K.; Rhodes, A.; Mepham, B.; Warford, A.; Kirkham, N. 1993: UK NEQAS for immunocytochemistry A review of recent results. Journal of Pathology 169(Suppl): 126A
Mckee, G.; Robinson, I. 1994: UK National Breast Screening Programme The cytopathologists role. Acta Cytologica 38(5): 865
Campbell, I.; Seal, D.V.; Hay, J.; Mcluckie, J.; Patterson, W. 1994: UK National Study of Legionella contamination of hospital transplant units Relevance of free-living amoebae. Journal of Medical Microbiology 41(Suppl 1): ABSTRACT 288
Cornish, J. 1994: UK Paediatric Bone Marrow Transplant Group National Registry. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 112
Hann, C.M. 1994: UK Poultry Research Liaison Group. British Poultry Science 35(5): 818-819
U.K.Prospective Diabetes Study Group 1993: UK Prospective Diabetes Study X Urinary albumin excretion over 3 years in diet-treated type 2, diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 36(10): 1021-1029
Hamilton, S.L.; Clemes, S.A.; Griffiths, P.L. 2008: UK adults exhibit higher step counts in summer compared to winter months. Annals of Human Biology 35(2): 154-169
Carruthers, D.J.; Mchugh, C.A.; Robins, A.G.; Thomson, D.J.; Davies, B.; Montgomery, M. 1994: UK atmospheric dispersion modelling system Validation studies. Gryning, S -E , Millan, M M NATO Challenges of Modern Society; Air pollution modeling and its application X 491-501
Rahman, S.; Emery, A.; Poulton, J. 1998: UK centres are not following the Royal College of Pathologists' recommendations for storage of Guthrie cards: a national policy is needed. Journal of Medical Genetics 35(3): 263
O'Brien,G. 2008: UK emergency preparedness a holistic response?. Disaster Prevention and Management: 2, 232-243
Wilson, P.; Cutler, R.R.; Clarke, F.V. 1996: UK evaluation of the BBL mycobacterial growth indicator tube for the detection of mycobacteria in clinical specimens. Abstracts of the General Meeting of the American Society for Microbiology 96: 3
Rickard,S.; Roberts,D.L. 2008: UK farming post reform the key marketing challenges. Journal Of International Food and Agribusiness: 1, 5-27
Williamson, L.M. 1995: U.K. guidelines for the irradiation of blood components. Transfusion Science 16(2): 135-137
Milburn,R.; Hall,L. 2008: UK hotels early check-out for good times. Hospitality Directions: , 1-6
Leeuwen,S.van 2008: UK hotels forecast the bigger the boom, the bigger the bust. Hospitality Directions: , 1-23
Cookson, B.D.; Valtz, N.; Marples, R. 1998: UK infection control team methicillin-resistant Staphylococcus aureus questionnaire Control information. Journal of Hospital Infection 40(Suppl A): P3168
Cookson, B.D.; Marples, R. 1998: UK infection control team methicillin-resistant Staphylococcus aureus questionnaire Descriptive data. Journal of Hospital Infection 40(Suppl A): P3169
Wardrope, J. 1992: UK major trauma outcome study. Bmj 305(6860): 1016
McClean,H.; Carne,C.; Bunting,P.; Bhaduri,S.; Fernandes,A.; Dhar,J.; Estreich,S.; Daniels,D. 2008: UK national audit of chlamydial infection management in sexual health clinics Case notes audit demography, diagnosis and treatment. International Journal Of Std and Aids: 7, 469-472
McClean,H.; Carne,C.; Bunting,P.; Bhaduri,S.; Fernandes,A.; Dhar,J.; Estreich,S.; Daniels,D. 2008: UK national audit of chlamydial infection management in sexual health clinics Case notes audit information-giving, partner notification and follow-up. International Journal Of Std and Aids: 7, 473-476
Carne, C.; McClean, H.; Bhaduri, S.; Bunting, P.; Fernandes, A.; Dhar, J.; Estreich, S.; Daniels, D. 2008: UK National Audit of chlamydial infection management in sexual health clinics. clinic policies audit. International Journal of Std and Aids 19(7): 477-479
Wilkinson, I.M.S. 1992: UK national audit of the care of common neurological disorders. Journal of Neurology Neurosurgery and Psychiatry 55(12): 1215
Miller, K.; Rhodes, A. 1995: UK national external quality assessment scheme for immunocytochemistry An overview. Pathology Research and Practice 191(7-8): 730
Barlow, D.H. 1995: UK prevalence study of urogenital ageing. Barlow, D H Royal Society of Medicine Services Round Table Series; Towards better recognition of urogenital ageing 5-6
U.Prospective Diabetes Study Group 1993: UK prospective diabetes study IX Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months diet therapy. Diabetologia 36(9): 835-842
Atkins, W.S.; Edwards, R.; Cuzick, J.; Wardle, J.; Northover, J.M.A. 1998: UK randomized controlled trial of once only flexible sigmoidoscopy screening Interim results. Gastroenterology 114(4 Part 2): A560
Kehinde, E.O.; Terry, T.R.; Mistry, N.; Horsburgh, T.; Sandhu, D.P.; Bell, P.R. 1995: UK studies on suramin therapy in hormone resistant prostate cancer. Cancer Surveys 23: 217-229
Ueki, M.; Taniguchi, M. 1997: UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. III. Antibacterial action of demethyl UK-1. Journal of Antibiotics 50(9): 788-790
Ueki, M.; Shibata, K.; Taniguchi, M. 1998: UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1. Journal of Antibiotics 51(9): 883-885
Moore, B.A.; Keir, R.F.; Stuart, E.F.; Stobie, A.; Wright, K.N. 1996: UK-112, 166 A novel muscarinic antagonist with selectivity over M-2 receptors. European Respiratory Journal Suppl 9(23): 30S
Wallis, R.M.; Alker, D.; Burges, R.A.; Cross, P.E.; Greengrass, P.M.; Mcintyre, P.; Quinn, P. 1994: UK-84149 A novel gut-selective spasmolytic with calcium antagonist activity. British Journal of Pharmacology 112(Proceedings Suppl ): 574P
Quinn, P.; Wallis, R.M. 1994: UK-84149 A potent and gut-selective spasmolytic in the anaesthetised dog. British Journal of Pharmacology 112(Proceedings Suppl ): 573P
Gingell, C.J.C.; Jardin, A.; Olsson, A.M.; Dinsmore, W.W.; Osterloh, I.H.; Kirkpatrick, J.; Cuddigan, M. 1996: UK-92, 480, a new oral treatment for erectile dysfunction A double-blind, placebo-controlled, once daily dose response study. Journal of Urology 155(5 Suppl): 495A
Eardley, I.; Morgan, R.J.; Dinsmore, W.W.; Pearson, J.; Wulff, M.B.; Boolell, M. 1996: UK-92,480, A new oral therapy for erectile dysfunction, a double-blind, placebo controlled trial with treatment taken as required. Journal of Urology 155(5 Suppl): 495A
Boolell, M.; Gepi Attee, S.; Gingell, C.; Allen, M. 1996: UK-92,480, a new oral treatment for erectile dysfunction A double-blind, placebo controlled crossover study demonstrating dose response with Rigi Scan and efficacy with outpatient diary. Journal of Urology 155(5 Suppl): 495A
Terrett, N.K.; Bell, A.S.; Brown, D.; Ellis, P. 1995: UK-92,480, a potent and selective inhibitor of type V-A CGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Abstracts of Papers American Chemical Society 210(1-2): MEDI 229
Axon, A.T. 1998: UK-Japan exchange programme: Japanese endoscopists in the general infirmary at Leeds. Japanese Journal of Clinical Oncology 28(9): 531-532
Barrett Lee, P.J.; Bliss, J.M.; Brown, J.; Brunt, M.; Cull, A.; Denton, S.; Earl, H.; George, D.; Gould, A.; Harnett, A.; Johnson, L.; Perren, T.; Raina, V.; Twentyman, P.; Yarnold, Y.R. 1996: UKCCCR Adjuvant Breast Cancer Trial. British Journal of Cancer 74(Suppl 28): 4
Houghton, J.; Meadow, H.; Lennon, T.; Northover, J.M.A. 1994: UKCCCR anal cancer trail. European Journal of Cancer 30A(Suppl 1): S29
Oakhill, A. 1994: UKCCSG studies of paediatric germ cell tumours. Jones, W G, Harnden, P, Appleyard, I Advances in the Biosciences; Germ cell tumours III 57-58
Laukkanen, R.M.T.; Elo, A.; Kukkonen Harjula, K.; Oja, P.; Uusi Rasi, K.; Vuori, I. 1995: UKK walk test as a measure of maximal aerobic power during walking training. Medicine and Science in Sports and Exercise 27(5 Suppl): S97
Cull, C.A.; Holman, R.R.; Turner, R.C. 1995: UKPDS 6 year trial of sulphonylurea, insulin and metformin therapy in type 2 diabetic patients with diet failure. Diabetologia 38(Suppl 1): A24
Widjaja, A.; Stratton, I.M.; Horn, R.; Holman, R.R.; Turner, R.C.; Brabant, G. 1996: UKPDS Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. Diabetologia 39(Suppl 1): A144
Stratton, I.M.; Turner, R.C. 1995: UKPDSProgression of sub-clinical indices of tissue damage over 6 years from diagnosis of type 2 diabetes. Diabetologia 38(Suppl 1): A19
Johnson, R.; Belger, M.; Postlethwaite, R.J.; Rigden, S.P.A.; Verrier Jones, K. 1998: UKTSSA Paediatric Task Force report on factors affecting paediatric kidney tramolant survival. Pediatric Nephrology 12(7): C61
Ansel, G.; Coyne, K.; Arnold, S.; Mimer, J.; Nelson, S.D. 1992: UL-FS 49 prevents ventricular tachycardia induced by tricyclic antidepressant overdose. Clinical Research 40(3): 747A
Vos, M.A.; Leunissen, J.D.; Van Der Zande, J.; Wellens, H.J. 1994: UL-FS 49, a rather selective blocker of the pacemaker current I-f has no effect on automatic ventricular arrhythmias occurring 24 hours after infarction. Journal of the American College of Cardiology 1994(SPEC ISSUE): 183A
Villante Umberto; Lepidi Stefania; Francia Patrizia; Vellante Massimo; Meloni Antonio; Palangio Paolo 2000: ULF fluctuations at Terra Nova Bay Antarctica. Annali di Geofisica 43(2): 217-227
Obermayer, A.; Goestl, K. 2008: ULkus am FuBrucken verursacht durch eine intermetatarsale Perforansvene. Phlebologie 37(1): 17-19
Garcia Feijoo, J.; Cuina Sardina, R.; Benitez Del Castillo, J.M.; Arias Puente, A.; Andres, M.V.; Garcia Sanchez, J. 1997: UMB in anterior uveitis associated with ankylosing spondylitis. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S525
Scerbo, M.; Larson, M.; Sommers, W.R.; Rodriguez, S.; Herzog, W.R.; Gurbel, P.A.; Stafford, J.L.; Ziskind, A.A. 1993: UMCATH A data-driven catheterization laboratory database and clinical reporting system with a network graphical user interface. Journal of the American College of Cardiology 21(2 Suppl A): 13A
Byrne, D.E.; Mcgarrick, J.; Ward, J.P.T. 1997: UMDS respiratory system courseware A computer-aided learning package for medical and dental undergraduate teaching. Journal of Physiology (Cambridge) 505P: 2P
Banerjee, M.; Thompson, D.S.; Lazzell, A.; Carlisle, P.L.; Pierce, C.; Monteagudo, C.; López-Ribot, J.é L.; Kadosh, D. 2008: UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Molecular Biology of the Cell 19(4): 1354-1365
GabrielFilho,A.; Lancas,K.P.; Guerra,S.P.; Paula,C.A.; Monteiro,L.A. 2008: UMEB - mobile drawbar test unit. Engenharia Agricola: 4, 782-789
Trujillo, J.; Martiez, L.; Ochoa, R.; Ventura, J.; Valdivia, I.; Garcia, M.; Lazo, E.; Delahanty, A. 1995: UMELISA for the quantification of anti-HBsAG. Biotecnologia Aplicada 12(2): 100-101
Dec Bronsvoort, B.M.; Makepeace, B.L.; Renz, A.; Tanya, V.N.; Fleckenstein, L.; Ekale, D.; Trees, A.J. 2008: UMF-078: a modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle. Parasites and Vectors 1(1): 18
Miller, D.A.; Herrington, S.M.; Higgins, J.C.; Schroeder, D.W. 1995: UMHW polyethylene in total joint replacement History and current technology. Wise, D L , Trantolo, D J , Altobelli, D E , Yaszemski, M J , Gresser, J D , Schwartz, E R Encyclopedic handbook of biomaterials and bioengineering, Part B: Applications, Vols 1 and 2 665-688